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Abstract 
Jacqueline D. Wright 
Understanding the decline in prevalence of hypertension in US adults  
between 1976-80 and 1999-02 
(Under the direction of June Stevens) 
 
The National Health and Nutrition Examination Survey (NHANES) is conducted to 
monitor the health and nutrition status of the United States (US) population. Results from the 
NHANES indicate that between 1976-80 and 1999-02 the prevalence of obesity doubled in 
the US while hypertension declined by 25 percent. Much attention has been focused on 
obesity as a risk factor for hypertension and on programs to reduce obesity prevalence in the 
population. The objective of the first paper was to estimate the effect of two sources of 
measurement error on the estimated prevalences of hypertension in the two surveys. In the 
second paper I estimated the effect of measurement error and selected risk factors on the 
difference in hypertension prevalence between 1976-80 and 1999-02.  
 
Blood pressure measurements were adjusted for use of inappropriate cuff size using 
previously published correction equations. I modeled the effect of zero end digit preference 
using different sets of assumptions. The adjustment for cuff size changed the age-adjusted 
prevalence of hypertension in 1976-80 from 34 to 31% and in 1999-02 from 25 to 26%. After 
the adjustment for cuff size, adjustment for end digit preference reduced the prevalence in 
1976-80 slightly more from 31 to 30% and in 1999-02 the prevalence was unchanged at 26%.  
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The prevalence difference was -8.6 percentage points (-11.4, -5.8) after 
standardization for age alone compared with -8.0 percentage points (-10.8, -5.1) after 
standardization for age, body mass index (BMI), sex, race-ethnicity, smoking, and education. 
This should not be interpreted as meaning that none of these factors affected the difference. 
The difference decreased to -4.8 percentage points (-7.5, -2.0) after correction for cuff size 
and increased to -14.7 percentage points (-17.6, -11.7) after standardization for BMI and age. 
Using observed blood pressure prevalence differences were greater in overweight and obese 
persons than in normal weight persons but were similar after adjustment for measurement 
error. Zero end digit preference and lack of adjustment for cuff size contributed to the 
apparent decline in hypertension prevalence. Standardization for BMI, age, sex, race-
ethnicity, education, and smoking did not explain the decline in hypertension seen between 
1976-80 and 1999-02.  
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 1. Introduction 
 
Overview 
High blood pressure is a well-identified risk factor for coronary heart disease and 
stroke (1, 2). There have been improvements in the detection, treatment and control of 
hypertension over the past 30 years, and declines have been seen in death rates from stroke 
and coronary heart disease (1, 3). There have been calls for increased education efforts to 
prevent the development of hypertension, and estimates from the National Health and 
Nutrition Examination Survey (NHANES) 2005-06 indicate that 29 percent of adults 18 
years and older have hypertension (4, 5).  Demographic characteristics, such as age, sex, 
race-ethnicity, are associated with blood pressure. Numerous other factors have been 
identified as associated with blood pressure including genetic predisposition, diet, physical 
activity, and obesity or weight change (2). The latest report from the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC) notes the increasing prevalence of obesity as a critical factor in the need to develop 
public health approaches to address hypertension in the population (1).  
 
The NHANES has been conducted periodically since the 1960’s to monitor the health 
and nutrition status of the United States (US) population. Results from the NHANES 
indicated that prevalence of hypertension declined between the 1970’s and early 1990’s; 
more recent data indicate that hypertension increased between the early 1990’s and 1999-02
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(3, 4, 6). Burt and coauthors estimated the prevalence of hypertension in 1976-80 among 
adults 18-74 years old as 31.8 percent, age-adjusted to the 1990 population (3). Glover and 
coauthors estimated the age-adjusted prevalence in 1999-02 among adults 20 years and older 
as 28.6 percent (7). They did not specify the population used for age adjustment. Fields and 
coauthors estimated the prevalence in 1999-00 among adults 18 years and older as 28.4 
percent, age-adjusted to the 2000 population (6). Since estimates from the 1970’s were age-
adjusted to the 1990 US population and estimates from 1999-02 and more recent years were 
age-adjusted to the 2000 US population one cannot compare the prevalences. Hajjar and 
coauthors incorrectly compare these estimates and conclude that the decline in hypertension 
has been reversed (8). Comparable estimates for 1976-80 and 1999-02 have not been 
published. 
 
Over the same period that saw the decline in prevalence of hypertension there was a 
doubling of the prevalence of obesity (3, 9, 10). One could hypothesize that increased use of 
antihypertensive medicine might explain the decline in hypertension prevalence. In analyses 
of systolic and diastolic blood pressures as continuous variables using NHANES data from 
1960-80 Kumanyika and coauthors concluded that declines in systolic blood pressure in older 
adults appeared to be attributable to use of antihypertensive medication (11). However 
persons reporting the use of antihypertensive medicine were defined as hypertensive, 
regardless of the level of measured blood pressure, thus the increased use of such 
medications over the past 30 years would be expected to have no effect or to increase the 
prevalence of hypertension (12-14).  
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Specific Aims 
The goal of this study was to gain insight into the unexpected decline in hypertension, 
given the increase in obesity prevalence using data on adults 20-74 years old from the 
NHANES in 1976-80 and 1999-02.  
 
We estimated the impact of two sources of error in blood pressure measurement on 
the prevalence of hypertension in 1976-80 and 1999-02: namely zero end digit preference 
and the use of cuffs of inappropriate size. I estimated the effects separately and in 
combination after adjusting the two surveys to a common age distribution. I modeled the 
effect of measurement error on the prevalence estimates and conducted sensitivity analyses 
on the assumptions used for the models. 
 
I estimated the effect of differences in putative risk factors between the surveys on the 
hypertension prevalence difference between 1976-80 and 1999-02. The putative risk factors 
examined included age, sex, race-ethnicity, body mass index (BMI), education, and cigarette 
smoking. The prevalence difference was the primary measure of effect. The prevalence 
difference is often the implied effect measure in reports on trends in prevalence without 
being explicitly calculated as such (8). For public policy decisions risk differences have been 
suggested as more useful effect measures than ratio measures because they more directly 
present excess occurrence of disease (15). These aims were met through analyses of extant 
data from the NHANES program. The NHANES provides data on the health and nutritional 
status of the United States population. The NHANES program uses a cross-sectional, 
multistage, probability design to sample the noninstitutionalized civilian population of the 
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US. Information is obtained through personal interview and physical examination. Data from 
two surveys were used to examine the decline in prevalence of hypertension with the 
concomitant increase in prevalence of obesity in the US population between 1976-80 and 
1999-02. 
 
Significance 
Public health approaches to encourage behavior modification and lifestyle changes 
have been identified as having benefit in hypertension treatment and control and in the 
important area of primary prevention of hypertension (1). The JNC 7 report re-emphasizes 
the prevalence of obesity as a contributing factor in the rise of blood pressure in the 
population. The concern over prevalence of overweight and obesity in the US is illustrated by 
the number of major public health policy initiatives that include weight management or 
obesity prevention as a focus (16-21).  The JNC 7 report calls for public health approaches 
aimed at shifting the distribution of the population’s blood pressure downward (1). This 
study of the difference in prevalence of hypertension between two survey periods has 
furthered our understanding of the factors that contributed to the decline in the population 
prevalence of hypertension. Improved understanding of these shifts in the population 
distributions of hypertension and of obesity will help us to devise successful approaches to 
lowering the population’s blood pressure.  
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2. Background 
Hypertension 
Definition 
Blood pressure is a continuously measured physiologic trait and the risk of adverse 
health consequences increases monotonically with blood pressure, thus the selection of a 
specific level of blood pressure to identify persons at increased risk of cardiovascular disease 
is somewhat arbitrary (1).  Because blood pressure is distributed continuously in a 
population, the level that is selected to define hypertension determines the prevalence in the 
population.  Changing the cutpoint for the definition may result in almost doubling the 
prevalence estimate, as seen in the Hypertension Detection and Follow-up Cooperative 
Program screening of persons 30-69 years where use of a cutpoint of diastolic blood pressure 
of 95 mmHg or greater resulted in a prevalence of 14.5 percent and a cutpoint of 90 mmHg 
or greater resulted in a prevalence of 25.3 percent (2). The JNC 7 Report defines 
prehypertension as a systolic blood pressure (SBP) of 120-139 mmHg or a diastolic blood 
pressure (DBP) of more than 80-89 mmHg (3). Stage 1 hypertension is defined as a SBP of 
140-159 mmHg or a DBP of 90-99 mmHg and Stage 2 hypertension is defined as a SBP of 
160 mmHg or higher or a DBP of 100 mmHg or higher. The definition of hypertension 
currently used by the JNC for the purpose of monitoring prevalence is if systolic blood 
pressure is 140 mmHg or higher or a diastolic blood pressure is 90 mmHg or higher or the 
person is currently being treated with anti-hypertensive medication (3). 
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The definition of hypertension used for diagnosis and for initiation of drug therapy 
has changed over time. The first report of the JNC was published in 1977 and recommended 
that patients with a DBP of 105 mmHg or greater should begin drug therapy and for patients 
with a DBP of 90 to 104 treatment should be determined in conjunction with consideration of 
other risk factors present (4). In 1984, the JNC 3 Report included systolic and diastolic 
cutpoints in the definitions used for diagnosis and drug therapy was recommended if diastolic 
blood pressure was persistently elevated above 95 mmHg or if systolic was persistently 
elevated above 160 mmHg (5). The JNC 5 Report, published in 1993, defined systolic blood 
pressure of 140 mmHg or higher and diastolic pressure of 90 mmHg or higher as “mild 
hypertension” because of concern that previously used terms did not emphasize the 
importance of cardiovascular disease risk (6). The JNC 6 Report continued the use of the 
cutpoints of 140 and 90 mmHg of systolic and diastolic pressure respectively, to define stage 
1 hypertension with the recommendation that drug therapy be started at stage 1 if target 
organ damage was present or if the patient had diabetes (7). In the 2003 JNC 7 report, drug 
therapy was recommended at pre-hypertensive blood pressure levels of 120-139 systolic and 
80-89 diastolic if compelling indications exist, including target organ damage, diabetes, or 
high coronary heart disease risk (3). One of the important messages of the 2003 JNC 7 
Report was identifying elevated systolic blood pressure as a more important risk factor for 
cardiovascular disease (CVD) than diastolic blood pressure (3). 
 
Trends 
The trends in blood pressure levels from 1960-91 in the US were examined using data 
from the NHANES (8). Hypertension was defined as a SBP of 140 mmHg or higher or a 
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DBP of more than 90 mmHg or current treatment with anti-hypertensive drugs (9). For 
persons aged 18-74 years, the prevalence of hypertension (age-adjusted to the 1990 US 
population) declined from 36.3 percent in 1971-74 to 20.4 percent in 1988-91 with the largest 
drop occurring between 1976-80 and 1988-91.  The same trend was seen in mean levels of 
systolic and diastolic blood pressures. Hajjar and Kotchen estimated the prevalence of 
hypertension (age-adjusted to the 2000 US population) in persons 18 years and older as 29 
percent using the NHANES 1999-00 (10). Using NHANES 1999-02, Glover and coauthors 
estimated that 29 percent of persons 20 years and older have hypertension (11). The latest 
estimates for NHANES 2005-06 indicate that 29 percent of adults 18 years and older have 
hypertension (12).  
 
The JNC 7 Report defined pre-hypertension as a SBP of 120-139 mmHg or a DBP of 
80-89 mmHg and persons with pre-hypertension are at increased risk to develop hypertension 
(3). Wang and coauthors and Greenlund and coauthors have examined the NHANES 1999-
00 and estimate that 31 percent of the population are prehypertensive (13, 14). Ostchega and 
coauthors estimate that the prevalence of prehypertension is 37 percent in 2005-06 (12). 
Greenlund and coauthors estimated that persons with prehypertension were 1.65 times more 
likely to have another risk factor for heart disease or stroke. Erlinger and coauthors focused 
on adults 65 years and older in the NHANES 1988-94 and estimated that 69 percent of those 
with hypertension had at least one other CVD risk factor, such as increased low density 
lipoprotein (LDL) cholesterol or diabetes (15).  
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Similar trends in hypertension prevalence have been seen in other studies in the US 
and in other countries. Researchers conducted two cross-sectional surveys of the seven-
county Twin Cities metropolitan area of Minnesota in 1980-82 and in 1985-87 (16).  
Households selected for the 1980-82 sample were ineligible for the 1985-87 sample.  The 
prevalence of hypertension decreased among both women (21.8 percent to 18.7 percent) and 
men (24.4 percent to 22.1 percent).  McGovern and coauthors documented a continuing 
decline in blood pressures in the 1990-92 survey (17). Sprafka and coauthors found 
decreasing mean blood pressures with concurrent increases in BMI (16).   
 
A study of trends in blood pressure in Finland from 1982 to 1987 found trends similar 
to those seen in the US (18).  The authors found that the proportion of obese adults 
(BMI>30) increased most in two subgroups: men who were aware of their hypertension but 
not on medication and hypertensive women who were on medication. In Australia the 
prevalence of hypertension decreased over the period 1980-89 from 26.7 to 18.8 percent in 
men 25-64 years and from 21.4 to 13.9 percent in women 25-64 years, and the decrease was 
primarily due to a decrease in the prevalence of undiagnosed hypertension (19). In New 
Zealand, over the period 1982-94, the prevalence of hypertension (defined as SBP/DBP 
greater than 150/90 mmHg) among those with no treatment decreased from 20.0 percent to 
10.6 percent in men 35-64 years and from 12.4 percent to 6.8 percent in women 35-64 years, 
with a slight decrease in the prevalence of those on antihypertensive medication (20).  
 
In Italy, between the periods 1978-79 and 1983-84, slight decreases in mean systolic 
and diastolic blood pressures were seen in adults 20-59 years (21). From three annual surveys 
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in Sweden between 1985-95, there was a minor but consistent increase in mean SBP and 
DBP across age groups in adults 25-64 years. The authors conclude that previous declines in 
blood pressure seem to have stopped (22). Data from the Scottish MONICA study 
(Monitoring Trends and Determinants in Cardiovascular Diseases) on adults 25-64 years old 
in North Glasgow, Scotland indicate that prevalence of hypertension declined from 29.8 to 
22.2 percent in men and from 23.2 to 15.2 percent in women using cutpoints of 160 mmHg 
or more systolic or 95 mmHg or more diastolic blood pressure (23). Danon-Hersch and 
coauthors reported a slight decline in mean blood pressure in adults 25-64 years old in 
Seychelles between 1989 and 2004, although there was little change in prevalence of 
hypertension (24). 
 
Risk factors  
Risk factors for hypertension include age, sex, race-ethnicity, body mass index, 
family history of hypertension, education, physical activity, and diet (25). Dietary factors 
include alcohol intake, sodium intake, potassium intake, calcium intake, and intake of fruits, 
vegetables, and low fat dairy foods (26). More recent research has identified sleep apnea as a 
risk factor for hypertension (27). 
 
Blood pressure tends to be higher among men than women and higher among African 
Americans than among non-Hispanic whites or Mexican Americans in the US (8). From the 
NHANES 1999-02, Glover and coauthors estimate that the age-adjusted prevalence of 
hypertension was 40.5 percent among non-Hispanic black persons, 27.4 percent among non-
Hispanic white persons, and 25.1 percent among Mexican Americans (11). Increases in blood 
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pressure with age have been seen in many but not all populations (8, 28, 29). There have 
been increases in educational attainment in the US with the percent of adults 25 years and 
older who completed high school or more education increasing from 52.3 percent in 1971 to 
66.5 percent in 1980 and to 80.4 percent in 2000 (30) 
 
A number of dietary factors have been associated with risk of hypertension.  Alcohol 
intake has been identified as a risk factor for high blood pressure, with a J-shaped or U-
shaped association (31).  Sodium intake is associated with risk of high blood pressure among 
individuals who are sodium-sensitive and low potassium intake is associated with high blood 
pressure, although its effect is influenced by sodium intake (32, 33).  Studies have 
investigated a protective effect of calcium intake against hypertension, through direct action 
on the vasculature or through effect on alpha 1-adrenegic activity (34, 35).  Harlan and 
coauthors determined that in the NHANES 1971-74, age and BMI were the best predictors of 
blood pressure although other factors contributed to blood pressure levels: dietary calcium, 
phosphorous, and sodium/potassium ratio, and alcohol intake (36).  However, Sempos and 
coauthors examined the association of calcium intake and blood pressure in NHANES 1971-
74 and NHANES 1976-80 and did not find evidence of an association (37). 
 
The National High Blood Pressure Education Program identified six risk factors as 
important for primary prevention efforts: inadequate physical activity, excess body weight, 
excess alcohol consumption, excess sodium intake, inadequate potassium intake, diet low in 
fruits, vegetables, and low-fat dairy products (38). The 2003 JNC 7 Report identified these 
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strategies as lifestyle modifications that were recommended for all persons with blood 
pressure at the pre-hypertensive level or higher (3).  
 
Pharmacologic treatment of hypertension 
Burt and coauthors examined the effect of treatment with medications on prevalence 
of hypertension (8).  The prevalence of treatment increased concurrent with the decreases in 
mean blood pressure levels.  They estimated that the rate of hypertension treatment increased 
from 37 to 72 percent in men with high blood pressure and from 62 to 86 percent in women 
with high blood pressure over the period from 1976-80 to 1988-91.  Effective 
antihypertensive pharmacologic treatments have become available over this time, including 
diuretics, beta blockers and angiotensin-converting enzyme (ACE) inhibitors. Studies have 
documented trends in the use of antihypertensive medication between 1973 and 1995 (39-
41). A decline in the use of diuretics in the 1980’s was documented in two different datasets 
(40, 41). Use of calcium channel blockers and ACE inhibitors increased after their approval 
in the early 1980’s.  
 
Kumanyika and coauthors investigated whether the decline in blood pressure seen in 
NHANES from 1960 to 1980 was due primarily to antihypertensive drug treatment and not to 
primary prevention (42).  Using a cumulative logit model, they found that the odds of having 
high systolic blood pressure with BMI≥25.0 decreased over the survey periods, after 
adjusting for sex, age, and race.  In order to estimate the effect of drug treatment, they 
imputed blood pressures for persons reporting drug treatment to what their blood pressures 
might have been had they not been on drug treatment.  For persons on treatment with systolic 
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blood pressure below the 90th percentile, they re-assigned values above the 90th percentile.  
They compared the trends seen with these imputed data to the trends seen in the observed 
data.  The declines in blood pressure levels in men 45-54 years and women 65-74 years were 
attributed to use of medication.  Nevertheless, this cannot explain the decrease in prevalence 
of hypertension seen from 1976-80 to 1988-91.  The definition of hypertension includes not 
only those with blood pressures above the 140/90 mmHg cutpoints, but also anyone reporting 
use of antihypertensive medication.  Using that definition, the increase in prevalence of drug 
treatment over the period from 1976-80 to 1988-91 might have been expected to have no 
effect or to increase the prevalence of hypertension over that period, but not to decrease it.   
 
Blood pressure measurement 
The American Heart Association (AHA) has regularly published recommendations on 
blood pressure measurement methods (43-45). The auscultatory method using mercury 
sphygmomanometer has long been recommended as the preferred method of blood pressure 
measurement in clinical settings and has been used widely in epidemiologic studies and all of 
the NHANES surveys. Variation in blood pressure measurement can occur as a result of 
many factors including recent food or caffeine intake, recent nicotine use, full urinary 
bladder, talking or background noise, subject’s physical position, time of day, subject’s 
emotional state, and recent activity. The most recent recommendations identify the observer 
as a critical component of accurate measurement. Observers must be properly trained and use 
calibrated equipment. 
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Methodological issues in blood pressure measurement may affect the prevalence 
estimates for hypertension in a population.  In the examination of trends in hypertension 
using NHANES, Burt and coauthors noted several important differences in the methods used 
to measure blood pressure in the different surveys (8).  There were differences in the 
proportion of measurements ending in zero (an indicator of digit preference by observer), 
what kind of measurement cuffs were available, the number of measurements taken, who 
took them (physician, nurse, or interviewer), the length of training, where measurements 
were taken (examination center or home), how often equipment was checked and calibrated, 
and the participant’s position (lying, sitting, or standing). 
 
Cuff size 
The AHA recommendations for blood pressure measurements discuss the error 
introduced by the use of inappropriately sized cuffs (43, 45).  The 1988 recommendations 
specified that the ratio of arm circumference to the width of the cuff bladder should be 0.4, 
although more recent research has suggested that optimal cuff width is proportional to the 
logarithm of arm circumference (45, 46).  A cuff bladder that is too narrow will result in 
overestimation of blood pressure, and a cuff bladder that is too wide will result in 
underestimation of blood pressure.  The error introduced by use of a cuff that is too narrow is 
greater than that introduced from a cuff that is too wide.  The 1988 AHA recommendations 
included correction factors that should be used when appropriately sized cuffs are not 
available. The 1988 AHA recommendations included corrections for blood pressures 
measured with incorrect cuffs based on a study by Maxwell and coauthors (43, 47). Maxwell 
and coauthors measured blood pressures in 1,240 obese patients using different cuff sizes and 
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developed formulas and corrections for systolic and diastolic pressures. As part of the 
Minnesota Heart Health Program’s 1988 survey of adults 25-74 years old, a study of the 
effect of cuff size on blood pressure measurement indicated systolic and diastolic pressures 
were overestimated by 2-6 mmHg in men and by 3-4 mmHg in women when cuff sizes were 
too small (16). 
 
In NHANES 1999-02, five different cuff sizes were available, including a large cuff 
and a thigh cuff, while in NHANES 1976-80 only a child-size and adult-size cuff were 
available. Ostchega and coauthors determined that in the 1999-2000 survey the ratio of cuff 
width to arm circumference accounted for less than two percent of the variability in all blood 
pressure readings (48). Mean mid-arm circumference increased across all age groups in 
adults 20 years and older between 1988-94 and 1999-02 in NHANES (49).  
 
Zero end digit preference 
Terminal digit preference can bias estimates of the prevalence of hypertension 
upward (50-52).  This can be illustrated in the following example, using a systolic blood 
pressure cutpoint of 140 mmHg to define hypertension.  If technicians or physicians are more 
likely to round up or down to a number ending in zero then measurements such as 136 or 138 
may be rounded up to 140, and that individual would be misclassified as hypertensive.  
Measurements such as 142 or 144 may be rounded down to 140, but in this case the 
individual would be classified as hypertensive regardless of rounding.  Rounding of any 
reading to numbers much higher than 140, such as rounding 146, 148, 152, or 154 to 150 will 
not effect whether an individual is classified as hypertensive.  Similarly, rounding of blood 
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pressures to numbers much lower than 140 will not affect hypertension classification.  
Rounding to the nearest number ending in zero only affects hypertension classification when 
a number lower than 140 (such as 136 or 138) is rounded up to 140.  Thus the effect of zero 
end digit preference is to overestimate the prevalence of hypertension in a population and to 
underestimate the prevalence of hypotension. In analysis of trends in NHANES, Burt and 
coauthors computed the proportion of zero end digits for each survey and it ranged from a 
low of 19 percent of systolic blood pressure measurements by physicians in NHANES 1988-
91 to a high of 52 percent of diastolic blood pressure measurements in NHANES 1976-80 
(8). In NHANES 1999-00, 21 percent of SBP readings and 23 percent of DBP readings 
ended in zero (48). 
 
Obesity  
Definition 
The physiologic functions of adipose or fat tissue include synthesis and storage of 
triacylglycerols during food digestion (53).  The metabolism of triacylglycerols provides 
energy for other tissue, notably muscle tissue, between meals.  Obesity was defined as “an 
excess of body fat frequently resulting in a significant impairment of health” at the 1985 
National Institutes of Health Consensus Workshop on the health implications of obesity (54). 
Various anthropometric measurements have been used to assess obesity and recent advances 
in technology have provided new and better measurement techniques.  The different 
measurements focus on different aspects of obesity.  Labarthe identifies the principal aspects 
of obesity that affect health as fatness, body fat distribution, and overweight (25).  Fatness is 
an excess of adipose tissue expressed as an absolute amount such as grams, or more 
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commonly as a relative amount such as percent body fat.  Body fat distribution is the 
distribution of adipose tissue in the body, with the primary focus on central or abdominal fat.  
Measures of body fat distribution include indices of circumferences such as waist-to-hip ratio 
and indices of skinfold thicknesses such as the ratio of subscapular skinfold to triceps 
skinfold.  Overweight is an excess of weight compared to some standard and is closely 
correlated with measures of fatness in the US  One study examining different measures of 
fatness found that absolute measures such as BMI and kilograms of fat tissue were stronger 
predictors of blood pressure than were relative measures such as percent body fat (55).  They 
hypothesized that this may be due to decreased measurement error in absolute measures such 
as body mass index.  The standard used to define overweight has varied from actuarial tables 
on weight and mortality published by the Metropolitan Life Insurance Company to the use of 
an index of weight and height, such as Quetelet’s Index of body mass index (weight in 
kilograms divided by height in meters squared) which is compared to a standard.  The Expert 
Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults 
adopted a set of classifications for BMI which defines overweight as a BMI of 25.0-29.9 and 
defines three classes of obesity for BMI values greater than 30.0 (56). In 2004, after 
consideration of the need for population-specific BMI cutpoints for obesity, an expert 
committee of the World Health Organization (WHO) concluded that population-specific 
cutpoints should not be defined, but ten BMI cutpoints should be used for reporting where 
possible: 18.5, 20.0, 23.0, 25.0, 27.5, 30.0, 32.5, 35.0, 37.5, and 40.0 (57). 
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Trends  
Trends in obesity in the US can be examined using data from NHANES (58).  These 
results use a definition of obesity as BMI≥30.0 and are for adults 20-74 years.  The age-
adjusted prevalence of obesity increased from 14 percent in 1976-80 to 22 percent in 1988-
94, while the prevalence of overweight, defined as a BMI of 25.0-29.9 showed little change.  
These trends were similar for all sex-age-race-ethnic groups. Hedley and coauthors provided 
estimates of the prevalence of overweight and obesity using the NHANES 1999-2002 (59). 
They estimated that 30 percent of adults 20 years and older were obese. Similar trends 
showing an increase in mean BMI have been reported in other studies.  In Australia, cross-
sectional surveys of adults 25-64 years old in 1980, 1983, and 1989 indicated increases in 
mean BMI in both sexes (19). In Göteborg Sweden, three cross-sectional surveys between 
1985 and 1995 in adults 25-64 years showed similar increases in mean BMI (22). In the 
Minnesota Heart Surveys in 1980-82 and 1985-87, in adults 25-74 years old, mean BMI 
increased in both sexes (16). 
 
Risk factors  
A wide variety of factors have been associated with obesity including demographic 
factors such as sex, age, race-ethnicity, and socioeconomic status, behavioral factors such as 
dietary habits, physical activity, and cigarette smoking, and other factors such as genetics, 
birthweight and concurrent illness (25).  Flegal and coauthors examined the trends in the 
relationship of BMI and socioeconomic status, defined using educational status and income 
level, over the NHANES from 1960-1980 (60, 61).  Among females 18-34 years, they 
identified a negative association between educational status and BMI that became stronger 
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over time.  The association of income level and BMI was less consistent across age and race 
categories.  Mean BMI was inversely associated with income in some categories, and the 
relationship was curvilinear for other categories, with mean BMI highest in the middle 
income group.  The trend across survey periods was for greater increase in mean BMI in the 
highest income group.  The main difference in the secular trends of the association of BMI 
with income and education was that “education became an increasingly more important 
factor and income became a less important factor…the greatest increases in BMI over time 
were found in those with the lowest levels of education” (60) (p. 541).  Among men Flegal 
and coauthors found that the relationship between BMI and income and BMI and education 
was weaker than it was among women.  There was a more positive association of BMI and 
income and than for the association of BMI and education. 
 
The association of lower body weight among smokers than among non-smokers was 
confirmed in the NHANES 1976-80 by Albanes and coauthors (62). Examining the 
NHANES 1988-91, Flegal and coauthors determined that smokers reported smaller weight 
gain over the past 10 years than persons who quit smoking over the same period (63).  They 
estimated that individuals were more likely to become overweight if they had quit smoking 
within the past 10 years (odds ratios of 2.0 for women and 2.4 for men). The results of the 
Minnesota Heart Surveys indicate that cigarette smoking declined 14 percent in men and 18 
percent in women over the same period that average BMI increased (16).  These results 
mirror national data that indicate that smoking declined from 42.4 percent in 1965 to 24.7 
percent in 1997 (64). Recently Flegal estimated the effect of decreases in smoking prevalence 
on obesity prevalence in the US (65). She concluded that only a 1.4 percentage-point drop in 
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the obesity prevalence would have occurred if the prevalence of smoking were at the higher 
rate seen in 1971-75. 
 
Association of hypertension and obesity 
Numerous epidemiologic studies have found an association of cardiovascular risk 
factors, such as blood lipids and blood pressure with obesity (36, 42, 66-70). Björntorp 
suggests obesity is an intermediate in the pathway from positive energy balance leading to 
diabetes and cardiovascular disease (71).  In this framework blood pressure, insulin, glucose, 
Very Low Density Lipoprotein (VLDL) cholesterol, and High Density Lipoprotein (HDL) 
cholesterol are secondary risk factors triggered by obesity and portal adipose tissue.  
 
Obesity has been associated with increased risk of hypertension and studies have 
specifically linked increases in BMI with increases in blood pressure (16, 29, 72, 73).  
Wilson and coauthors found that obesity was highly related to incident hypertension in an 
analysis of the Framingham Heart Study participants 35 to 75 years old (72). Researchers 
conducting the International Cooperative Study on the Relation of Sodium and Potassium to 
Blood Pressure (INTERSALT) found on average a 10 kg difference in body weight was 
associated with a 3 mmHg difference in systolic blood pressure and a 2.2 mmHg difference 
in diastolic blood pressure (29). Burt and coauthors examined blood pressure by quintile of 
BMI in NHANES 1988-91 (8). Mean blood pressure level and prevalence of hypertension 
increased with increasing quintile of BMI for the period 1988-1991. Gregg and coauthors 
recently examined trends in cardiovascular disease risk factors by BMI in the NHANES and 
concluded that declines in prevalence of high blood pressure did not differ by BMI (74). 
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Okosun and coauthors examined waist circumference as a measure of abdominal obesity in 
the NHANES 1988-94 (75). They found that abdominal obesity was associated with a two- 
to three-fold increase in risk of hypertension. Must and coauthors examined overweight and 
obesity in relation to cardiovascular disease risk factors in NHANES 1988-94 (76). For 
persons less than 55 years, odds of high blood pressure across categories of obesity ranged 
from 2.52-4.60 for men and from 3.22-5.45 for women.  More moderate risks were seen in 
ages 55 years and older. Brown and coauthors also examined the association of BMI and 
hypertension in NHANES 1988-94, using different categories and methods (77). Odds ratios 
for hypertension were greater for ages 20-39 years than for older age groups. The association 
of BMI and hypertension was stronger for the younger age group. Flegal commented on the 
analyses by Must and coauthors and by Brown and coauthors pointing out that given the high 
prevalence of hypertension seen in persons 60-79 years old, even if older persons all had 
BMI levels below 25.0, the prevalence of hypertension might not be greatly reduced (78). 
Kumanyika and coauthors examined trends in blood pressure and associations with BMI and 
race over the NHANES from 1960 to 1980 (42).  After estimating the effect of increasing use 
of antihypertensive drugs over time, they concluded that while medication accounted for 
much of the decrease in systolic blood pressure, race and overweight were still associated 
with high blood pressure. 
 
The pathophysiologic mechanisms for the association of obesity with hypertension 
remain unclear although increased sympathetic nervous system activity plays a role (79). 
Previous research has indicated sodium retention plays a role in obesity-associated 
hypertension (80). There are many mechanisms that have been suggested to explain the 
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increased risk of hypertension with obesity, including metabolic factors such as leptin and 
adiponectin, sleep apnea, and intestinal bacteria (81-83). 
 
Conclusion 
There were methodologic differences between the NHANES surveys that may in part 
affect estimates of prevalence of hypertension from the surveys and estimates of the 
difference.  Further analysis is needed to determine whether or not these methodologic 
differences affect the difference in hypertension between 1976-80 and 1999-02. A number of 
researchers have investigated factors associated with the prevalence of hypertension in the 
US using the NHANES (42, 76, 77, 84). Researchers have found body mass index and waist 
circumference are associated with blood pressure levels (42, 74-77). Other factors associated 
with blood pressure including race-ethnicity, use of anti-hypertensive medication, and certain 
dietary factors have been associated with trends in hypertension in the NHANES (11, 36, 
42). This research will examine the difference in hypertension between 1976-80 and 1999-02 
using the NHANES. Analysis of these national survey data will improve the understanding of 
the secular trends in hypertension in the US. 
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3. Effects of Measurement Error on Prevalence of Hypertension from the 
National Health and Nutrition Examination Survey (NHANES),              
1976-80 and 1999-02 
 
Abstract 
The National Health and Nutrition Examination Survey (NHANES) data from 1999-
02 showed a decline in hypertension prevalence from NHANES II (1976-80). The objective 
of this study was to estimate the effect of two sources of measurement error on the estimated 
prevalences of hypertension in the two surveys. The analytic sample of persons 20-74 years 
old consisted of 11,712 participants from 1976-80 and 7,734 participants from 1999-02 for 
whom two complete blood pressure measurements were available. Observations were 
adjusted for end digit preference and for use of inappropriate cuff size. The adjustment for 
cuff size changed the estimated prevalence of hypertension in 1976-80 from 34 to 31% and 
in 1999-02 from 25 to 26%. After the adjustment for cuff size, the adjustment for end digit 
preference reduced the estimated prevalence in 1976-80 only slightly from 31 to 30% and in 
1999-02 the prevalence was unchanged at 26%. Zero end digit preference and lack of 
adjustment for cuff size may have contributed to the apparent decline in hypertension 
prevalence; however, these sources of measurement error do not appear to entirely explain 
the decline. Analyses of hypertension should include evaluation of these sources of error. 
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Introduction 
The National Health and Nutrition Examination Survey (NHANES) has been 
conducted periodically since the 1960’s to monitor the health and nutrition status of the US 
population. Over the past 25 years the results from the NHANES have indicated a decline in 
the prevalence of hypertension 1-3. Burt and coauthors estimated the prevalence of 
hypertension in 1976-80 among adults 18-74 years old as 31.8 percent, age-adjusted to the 
1990 population 1. Glover and coauthors estimated the age-adjusted prevalence in 1999-02 
among adults 20 years and older as 28.6 percent 3. They did not specify the population used 
for age adjustment. Fields and coauthors estimated the prevalence in 1999-00 among adults 
18 years and older as 28.4 percent, age-adjusted to the 2000 population 2. Comparable 
estimates for 1976-80 and 1999-02 have not been published. 
 
Differences seen between surveys could in part be caused by differences in 
measurement techniques and equipment. For example, blood pressure measurements are 
susceptible to bias associated with observer preference for a particular end digit, commonly 
zero. Since hypertension is usually defined using values ending in zero, for example a 
diastolic blood pressure of 90 mmHg or higher, end digit preference can bias estimates of the 
prevalence of hypertension upward 4,5.  If observers are more likely to round up to a number 
ending in zero, then diastolic blood pressure measurements such as 86 or 88 may be rounded 
up to 90, resulting in misclassification.  Diastolic measurements such as 92 or 94 may be 
rounded down to 90, but the individual’s classification as hypertensive would not change.  
Thus the effect of zero end digit preference would be to overestimate the prevalence of 
hypertension in a population. 
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Another methodologic factor that could impact blood pressure measurement across 
surveys was the use of blood pressure cuffs of different widths 1. The 1988 American Heart 
Association (AHA) recommendations specify that the ratio of arm circumference to the width 
of the cuff bladder should be 0.4 and include correction factors that should be used when 
appropriately sized cuffs are not available 6,7. In the NHANES 1976-80 two widths of blood 
pressure cuffs were available. In 1999-02 in addition to the cuff widths used in 1976-80, two 
larger cuff widths were also available. For persons with larger arm circumferences who 
needed larger cuffs, blood pressure might have been overestimated in 1976-80.  This would 
result in overestimation of hypertension prevalence in 1976-80 and may have contributed to 
the observed decline in hypertension prevalence between 1976-80 and 1999-02. 
 
The objective of this paper was to estimate the effect of two sources of measurement 
error on the prevalence of hypertension in 1976-80 and 1999-02: namely zero end digit 
preference and the use of cuffs of inappropriate size. We examined the effects of the two 
sources of measurement error separately and in combination after adjusting the two surveys 
to a common age distribution. We modeled the effect of measurement error on the prevalence 
estimates and conducted sensitivity analyses on the assumptions used for the models. 
 
Methods 
The NHANES uses a cross-sectional survey design with nationally representative 
probability samples. Information is obtained through personal interview and physical 
examination at a mobile exam center (MEC). The 1976-80 sample included persons 6 months 
  34 
through 74 years old, and consisted of 27,801 eligible persons, of whom 25,286 (91%) were 
interviewed in the household and 20,322 (73%) were examined.  The examined sample 
included 11,864 adults 20-74 years old. A detailed description of the survey design and 
operation has been published elsewhere 8. The 1999-02 sample covered all ages, and 
consisted of 25,316 persons, of whom 21,004 (83%) were interviewed in the household and 
19,759 (78%) were examined. The examined sample included 8, 307 adults 20-74 years old. 
Detailed information on the survey design and data collection procedures is available at the 
NHANES website http://www.cdc.gov/nchs/nhanes.htm 9,10. The NHANES 1976-80 covered 
ages 6 months- 74 years old and NHANES 1999-02 covered all ages.  The analyses in the 
present study were restricted to adults 20-74 years old, an age range covered in both surveys. 
 
In both of the surveys, observers followed the then current AHA recommendations on 
blood pressure measurement. In 1976-80 two seated blood pressure measurements were 
taken at the mobile exam center, one at the beginning of the physician’s exam and one 
immediately following the recumbent blood pressure measurement. Of the adults 20-74 years 
old, 152 persons (1.3 percent) were missing one or more of the blood pressure measurements. 
The analytic sample consisted of 11,712 participants for whom two complete blood pressure 
measurements were available. In 1999-02 three seated blood pressure measurements were 
taken as part of the physician’s exam at the mobile exam center. A fourth measurement was 
attempted when necessary, in order to obtain three measurements on all examinees. Of the 
8,307 adults 20-74 years old who participated in an exam, 362 persons (4.4 percent) failed to 
complete the blood pressure component and 211 persons (2.6 percent) had less than two 
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complete blood pressure measurements. The analytic sample consisted of 7,734 participants 
for whom two complete blood pressure measurements were available. 
 
In both surveys blood pressures were taken using a mercury sphygmomanometer and 
physicians were instructed to record blood pressures to the nearest two mmHg. For this 
analysis, hypertension was defined using the current definition of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC) 11.  A person was defined as hypertensive if they had a systolic blood pressure of 140 
mmHg or higher or a diastolic blood pressure of 90 mmHg or higher or reported currently 
being treated with anti-hypertensive medication. This definition was applied to the mean of 
the two measurements in 1976-80 and to the mean of two or three measurements in 1999-02.   
 
The anthropometry component included measurement of several circumferences. In 
both surveys mid-arm circumference was measured to the nearest millimeter at the midpoint 
between the acromial and olecranon processes, on the right side unless that was not possible 
8-10
. In addition, in 1999-02 mid-arm circumference was measured by the physician just prior 
to blood pressure measurement in order to determine the appropriate cuff size. 
 
In 1976-80 physicians recorded 2-3 percent of the measurements in numbers with odd 
end digits, primarily numbers ending in five. For this analysis, these observations were 
randomly adjusted to the nearest number ending in an even digit. For example, a systolic 
blood pressure reading recorded as 135 mmHg was randomly adjusted to either 134 or 136 
mmHg. 
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End Digit Preference 
The prevalence of hypertension was estimated after applying adjustments to the 
observed data using two different sets of assumptions: one extreme and the second more 
probable. The first set assumed that all observations at the cutpoints of 140 mmHg systolic 
blood pressure and 90 mmHg diastolic blood pressure had been rounded up improperly from 
lower values. We adjusted all observations at 140 mmHg systolic blood pressure to 138 
mmHg and similarly adjusted the diastolic blood pressures at 90 to 88 mmHg. 
 
The second, more probable, set of assumptions used the mean and standard deviation 
of the first systolic blood pressure measurement in 1976-80 to calculate the expected relative 
frequency of observations at 140 (48.5 percent) and 138 (51.5 percent) assuming a log 
normal distribution (table 3.1). We adjusted the observed data so that the relative frequency 
of observations at 140 and 138 mmHg was equal to that expected in a log normal 
distribution. In the 1976-80 observed data, the relative frequencies at 140 mmHg were 69.1 
percent and 76.6 percent for the two measurements, and 30.9 percent and 23.4 percent at 138 
mmHg. We randomly selected observations at 140 mmHg to adjust to 138 mmHg. Diastolic 
blood pressures were adjusted in a similar fashion. 
 
Adjustment for Blood Pressure Cuff Width 
In 1976-80 blood pressure cuffs of two widths were available: one 9-cm cuff and one 
12-cm cuff. In contrast in 1999-02, five cuff sizes were available: a 6-cm cuff, a 9-cm cuff, a 
12-cm cuff, a 15-cm cuff, and an 18-cm cuff. The 1988 AHA recommendations for blood 
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pressure measurement included corrections for blood pressures not measured with 
appropriate cuff size that were based on equations developed by Maxwell and coauthors 6,7. 
We used these equations to adjust the observed blood pressures. In 1976-80, there were 26 
participants who were measured with the 9-cm cuff for one of the two measurements. In 
1999-02, there was one participant measured with the 6-cm cuff and 217 participants 
measured with the 9-cm cuff for all measurements. For these participants, cuff size 
adjustments were made using the formula for a 12-cm cuff. We estimated the prevalence of 
hypertension using the observed data and the adjusted data. 
 
Statistical Methods 
Analyses were conducted using SAS (v.9.1.3, SAS Institute, Cary, NC) and 
SUDAAN (v.9.0.1, Research Triangle Institute, Research Triangle Park, NC).  In order to 
produce nationally representative estimates of hypertension, sample design variables and 
examined sample weights were used. The sample weights incorporate differential 
probabilities of selection and adjustments for oversampling, noncoverage, and nonresponse 
12-14
. For  both the 1976-80 and 1999-02 surveys, estimates for persons 20-74 years old were 
adjusted by the direct method to the 2000 US population age distribution using the following 
age groupings: 20-39 years, 40-59 years, and 60-74 years. 
 
Results 
The distributions of selected demographic and physical characteristics are shown for 
both surveys (table 3.2). In the later survey there were fewer participants 20-39 years old and 
a larger percentage between the ages of 40-59 years. The percentage of non-white 
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participants increased between the two surveys as did the percentage of the population with 
more than a high school education. 
 
In 1976-80, the proportion of zero end digits was higher than in 1999-02 (table 3). 
The higher frequency of observations ending in zero in 1976-80 is illustrated in the 
distributions for each measurement (figure 3.1). In all of the 1976-80 blood pressure 
measurements spikes can be seen at values ending in zero. In the 1999-02 blood pressure 
measurements similar spikes at values ending in zero are not seen (figure 3.2).  
 
Using the mean of the two measurements in 1976-80, the age adjusted prevalence of 
hypertension was 34.2 percent (95 percent confidence interval: 31.9, 36.5) (table 3.4). After 
adjusting for end digit preference with the assumption that all observations at the cutpoints of 
140 mmHg systolic blood pressure and 90 mmHg diastolic blood pressure were rounded up 
from 138 and 88 respectively, the age-adjusted prevalence of hypertension was slightly lower 
at 31.8 percent. After adjusting for end digit preference using the expected relative 
frequencies, the prevalence was 32.8 percent. After adjusting for inappropriate cuff size the 
prevalence was 31.0. The joint effect of adjusting for end digit preference and inappropriate 
cuff size appeared to be less than additive. When the blood pressure observations were 
adjusted for end digit preference (assuming that all observations were rounded up) and for 
inappropriate cuff size the prevalence was 30.1 percent. When the blood pressure 
observations were adjusted for end digit preference (using the relative frequencies) and for 
inappropriate cuff size the prevalence was 30.4 percent. 
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The difference in the age-adjusted prevalence of hypertension in 1976-80 and in 
1999-02 was 9.3 percentage points. This difference was reduced after making adjustments for 
end digit preference (figure 3.3). The reduction in the difference was larger in models that 
adjusted for end digit preference with the more extreme assumption that all observations 
were rounded up than after adjusted using the expected relative frequencies. The reduction in 
the difference when adjusted for inappropriate cuff size was larger than either of the 
adjustments for end digit preferences. Adjustment for both end digit preference and for use of 
inappropriate cuff size reduced the difference more than either adjustment did separately. 
 
The same adjustments that were applied to the 1976-80 data were applied to the 1999-
02 data (table 3.4). The prevalence of hypertension in 1999-02, based on the observed mean 
of three measurements was 24.9 percent (95 percent confidence interval: 23.1, 26.7).  
After adjusting for end digit preference with the assumption that all observations at the 
cutpoints of 140 mmHg systolic blood pressure and 90 mmHg diastolic blood pressure were 
rounded up, the age-adjusted prevalence of hypertension was slightly lower at 24.3 percent. 
After adjusting for end digit preference using the expected relative frequencies, the 
prevalence was 24.8 percent. After adjusting for inappropriate cuff size the prevalence was 
slightly higher at 25.9. The joint effect of adjusting for end digit preference and inappropriate 
cuff size was smaller than the adjustment for inappropriate cuff size alone. When the blood 
pressure observations were adjusted for end digit preference (assuming that all observations 
were rounded up) and for inappropriate cuff size the prevalence was 25.7 percent. When the 
blood pressure observations were adjusted for end digit preference (using the expected 
relative frequencies) and for inappropriate cuff size the prevalence was 25.9 percent. 
  40 
 
Discussion 
This study estimated the effect of measurement error in blood pressure measurement 
in 1976-80 and 1999-02 in the NHANES. The adjustment for cuff size changed the estimated 
prevalence of hypertension in 1976-80 from 34 to 31 percent and in 1999-02 from 25 to 26 
percent. In 1976-80 the adjustment for use of cuffs of inappropriate width decreased the 
prevalence of hypertension more than for the 1999-02 prevalence estimate. The relatively 
small effect of cuff width adjustment on the 1999-02 data is not surprising given the findings 
by Ostchega and coauthors 15. They compared arm circumferences with the cuff size used for 
measurement for NHANES 1999-00 and determined that 89% of persons were correctly 
measured with the 12 cm cuff, 92% were correctly measured with the 15 cm cuff, and 94% 
were correctly measured with the 18 cm cuff 15. 
 
The 1988 AHA recommendations note that a cuff bladder that is too narrow will 
result in overestimation of blood pressure, and a cuff bladder that is too wide will result in 
underestimation of blood pressure 6. The error introduced by use of a cuff that is too narrow 
is greater than that introduced from a cuff that is too wide. The AHA recommended that the 
corrections for cuff size be applied in research studies where accuracy is important. The 
corrections are based on a study by Maxwell and coauthors comparing blood pressure 
measurements on individuals using cuffs of three different widths 7. They used a sample of 
obese subjects to develop their correction equations since previous studies only compared the 
use of different size cuffs among normal weight subjects 7. Error due to an inappropriately 
small cuff size is more likely to occur among obese persons as they would be more likely to 
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require the larger size cuffs. We recommend that the AHA recommendation to apply 
corrections for use of cuffs of inappropriate width be followed when analyzing hypertension 
data. 
 
The effect of end digit preference among observers was modeled using a worst case 
assumption and a more probable assumption. Neither of these adjustments for end digit 
preference were developed using an independent dataset as were the correction equations for 
cuff size. The adjustments allow the estimation of the effect of end digit preference, but 
should not be applied to future analyses of the hypertension data. The adjustment for end 
digit preference after modeling the worst case assumption changed the estimated prevalence 
of hypertension in 1976-80 from 34 to 32 percent and in 1999-02 from 25 to 24 percent. The 
adjustment for end digit preference using the expected relative frequencies changed the 
estimated prevalence in 1976-80 from 34 to 33 percent and in 1999-02 the estimated 
prevalence remained unchanged at 25 percent. Given the adjustment for cuff size, the 
adjustment for end digit preference changed the estimated prevalence in 1976-80 only 
slightly from 31 to 30 percent and in 1999-02 the estimated prevalence remained unchanged 
at 26 percent.  
 
The importance of zero end digit preference as a source of misclassification of 
hypertension rests upon the fact that the definition of hypertension uses cut points ending in 
zero: namely 140 and 90 mmHg. It is this characteristic of the definition that causes zero end 
digit preference to overestimate the prevalence. If the definition was not inclusive, that is if 
the definition were greater than 140 mmHg systolic or greater than 90 mmHg diastolic, then 
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the bias would have been downward. Defining hypertension with values ending in digits 
other than zero could alleviate the error from end digit preference, however, such a definition 
may be more difficult to use in clinical settings and may convey a level of precision in the cut 
points that is not warranted. 
 
Other factors may have affected the prevalence estimates as well. The JNC has 
consistently recommended that evaluation for hypertension be based on a mean of multiple 
measurements and that an initial high reading is confirmed in at least two subsequent visits. 
While both of the surveys obtained multiple measurements, in 1976-80 only two 
measurements were obtained while in 1999-02 three measurements were collected. This may 
contribute to differences in the prevalence estimates and to differences in the effects of 
measurement error. In addition, the NHANES data were based on one exam and thus were 
subject to some misclassification error. 
 
In the current study, the effect of measurement error was greater in one survey time 
period than the other. In addition one type of error, error due to cuff size, was more important 
than another, error due to end digit preference. Although this conclusion cannot be 
generalized beyond the present study, it serves to underscore the need for evaluation of 
potential sources of error in blood pressure measurement. The effects of these two sources of 
error in blood pressure measurement on the estimated prevalence of hypertension in 1976-80 
and, to a lesser extent, in 1999-02 illustrates the importance of examination of potential 
sources of measurement error, and where possible, the adjustment of estimates such as 
prevalence. These sources of measurement error may have contributed to the apparent 
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decline in hypertension prevalence from 1976-80 to 1999-02; however, they do not appear to 
entirely explain the decline. 
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Table 3.1. Relative frequency (%) of observations at hypertension cutpoints in the National Health and Nutrition Examination Survey, 
1976-80 and 1999-02 
 1976-80 measurements 1999-02 measurements 
Systolic pressure (mmHg) First Second Expected First Second Third Expected 
140 69.1 76.6 48.5 57.5 47.0 55.4 48.6 
138 30.9 23.4 51.5 42.5 53.0 44.6 51.4 
Diastolic pressure (mmHg)        
90 74.6 68.8 47.6 54.3 54.4 48.2 41.9 
88 25.4 31.2 52.4 45.7 45.6 51.8 58.1 
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Table 3.2. Summary of Selected Demographic Characteristics* 
 1976-80 1999-02 
Sex 
% (SE) 
  
Male 47.6 (0.50) 48.5 (0.49) 
Female 52.4 (0. 50) 51.5 (0.49) 
Age in years 
% (SE) 
  
20-39 48.3 (0.84) 42.9 (0.99) 
40-59 33.5 (0.56) 40.8 (0.81) 
60-74 18.2 (0.56) 16.2 (0.58) 
Race-ethnicity 
% (SE) 
  
Non-Hispanic white 82.6 (1.40) 70.4 (1.78) 
Non-Hispanic black 10.0 (1.25) 11.2 (1.23) 
Other 7.3 (0.98) 18.4 (2.11) 
Education 
% (SE) 
  
Less than high school 32.7 (0.97) 23.5 (1.25) 
High school 35.6 (0.83) 25.8 (1.92) 
More than high school 31.6 (1.08) 50.7 (2.22) 
Poverty Income Ratio 
Mean (SE) 
2.73 (0.032) 3.03 (0.062) 
Hypertension 
% (SE) 
34.2 (1.11) 24.9 (0.88) 
Systolic blood pressure 
Mean (SE) 
126 (0.6) 122 (0.4) 
Diastolic blood pressure 
Mean (SE) 
80 (0.5) 73 (0.3) 
Body Mass Index 
Mean (SE) 
25.3 (0.07) 28.1 (0.14) 
Mid-arm circumference 
Mean (SE) 
31.3 (0.07) 33.0 (0.09) 
* Estimates were adjusted by the direct method to the 2000 US population 
using the following age groups: 20-39 years, 40-59 years, and 60-74 years.
  
Table 3.3. Distribution of end digits (%) for blood pressure measurements in the National Health and Nutrition Examination Survey, 
1976-80 and 1999-02 
 1976-80 Measurements  1999-02 Measurements 
 Systolic  Diastolic  Systolic  Diastolic 
End 
Digit 
First Second  First Second  First Second Third  First Second Third 
0 52 47  52 49  21 20 20  25 24 23 
2 9 9  8 8  18 19 19  17 17 17 
4 13 13  14 15  23 23 22  20 19 20 
6 14 15  13 13  21 21 21  19 20 20 
8 13 15  13 15  17 18 17  19 19 20 
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Table 3.4. Age-adjusted* prevalence of hypertension among adults 20-74 years old in the National Health and Nutrition Examination 
Survey, 1976-80 and 1999-02 before and after adjustment for end digit preference and inappropriate blood pressure cuff width 
 % 
 1976-80 1999-02 
Observed 
 
34.2 24.9 
Zeroes adjusted down 
 
31.8 24.3 
Zeroes adjusted to log normal 
 
32.8 24.8 
Cuff width adjustment 31.0 25.9 
Combined cuff width adjustment and zeroes adjusted down 30.1 25.7 
Combined cuff width adjustment and zeroes adjusted to log normal 30.4 25.9 
* Estimates were adjusted by the direct method to the 2000 US population 
using the following age groups: 20-39 years, 40-59 years, and 60-74 years. 
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4. Understanding the decline in prevalence of hypertension in US adults              
between 1976-80 and 1999-02 
 
Abstract 
Results from the National Health and Nutrition Examination Survey (NHANES) 
indicate that between 1976-80 and 1999-02 the prevalence of obesity doubled in the United 
States while hypertension declined by 25 percent. We estimated the effect of measurement 
error and selected risk factors on the difference in hypertension prevalence between 1976-80 
and 1999-02 using cross-sectional data from NHANES. The analytic sample of persons 20-
74 years old consisted of 11,712 participants from 1976-80 and 7,734 participants from 
1999-02. After adjustment for inappropriate cuff size the prevalence difference was 
attenuated; the age-standardized prevalence difference decreased from -8.6 percentage points 
(95 percent confidence interval: -11.4, -5.8) to -4.8 percentage points (95 percent confidence 
interval: -7.5, -2.0). A trend of increasing prevalence difference with BMI was also 
attenuated after adjustment for measurement error. The difference increased to -14.7 
percentage points (95 percent confidence interval: -17.6, -11.7) after standardization for BMI 
and age. The prevalence difference was -8.0 percentage points (95 percent confidence 
interval: -10.8, -5.1) after standardization for age, BMI, sex, race-ethnicity, smoking, and 
education. Adjustment for two sources of measurement error and standardization for BMI, 
age, sex, race-ethnicity, education, and smoking did not explain the decline in hypertension 
seen between 1976-80 and 1999-02.  
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Introduction 
Data from the National Health and Nutrition Examination Survey (NHANES) are 
used to track health indicators in the US population, including prevalence of hypertension 
and obesity. Over the same period that saw the doubling of prevalence of obesity, the US 
adult population experienced a 25 percent decline in the prevalence of hypertension from 34 
to 25 percent (age-adjusted to the 2000 US population) (1-3). One could hypothesize that 
increased use of antihypertensive medicine might explain the decline in hypertension 
prevalence. In analyses of systolic and diastolic blood pressures as continuous variables 
using NHANES data from 1960-80 Kumanyika and coauthors concluded that declines in 
systolic blood pressure in older adults appeared to be attributable to use of antihypertensive 
medication (4). However when persons reporting the use of antihypertensive medicine are 
defined as hypertensive, regardless of the level of measured blood pressure, the increased use 
of such medications over the past 30 years would be expected to have no effect or to increase 
the prevalence of hypertension (5-7).  
 
The goal of this work is to gain insight into the unexpected trends in hypertension, 
given the increase in obesity prevalence using data from the NHANES surveys in 1976-80 
and 1999-02. We first estimated the impact of two sources of error in blood pressure 
measurement which we have previously  shown to differ between surveys: incorrect cuff size 
and zero end digit preference (8).  We then considered whether differences in putative risk 
factors between the surveys may have contributed to differences in the prevalence of 
hypertension in US adults in 1976-80 compared to 1999-02.  The putative risk factors 
examined included age, sex, race-ethnicity, cigarette smoking and BMI.  The prevalence 
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difference was selected as the primary measure of effect for this analysis.  The prevalence 
difference is often the implied effect measure in reports on trends in prevalence without 
being explicitly calculated as such (9). For public policy decisions risk differences have been 
suggested as more useful effect measures than ratio measures because they more directly 
present excess occurrence of disease (10).  
 
Methods 
Study Population 
The NHANES used a cross-sectional survey design with nationally representative 
probability samples. Information was obtained through personal interview and physical 
examination at a mobile exam center. The 1976-80 sample included persons 6 months 
through 74 years old, and consisted of 27,801 eligible persons, of whom 25,286 (91%) were 
interviewed in the household and 20,322 (73%) were examined.  The examined sample 
included 11,864 adults 20-74 years old. A detailed description of the survey design and 
operation has been published elsewhere (11). The 1999-02 sample covered all ages and 
consisted of 25,316 persons, of whom 21,004 (83%) were interviewed in the household and 
19,759 (78%) were examined. The examined sample included 8,307 adults 20-74 years old. 
Detailed information on the survey design and data collection procedures is available at the 
NHANES website http://www.cdc.gov/nchs/nhanes.htm (12, 13). The analyses in the present 
study were restricted to adults 20-74 years old, an age range covered in both surveys. 
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Measurements 
Both the 1976-80 and 1999-02. surveys included questions on national origin or 
ancestry, but more specific information was collected on Mexican, Hispanic, or Latino 
ancestry in 1999-02. In addition information on race was collected by observation in 1976-80 
and was self-reported in 1999-02. The available information in 1976-80 was used to create 
categories similar to those available in the 1999-02 survey (14, 15). In both surveys smoking 
status was categorized as never smokers (defined as persons who reported not smoking at 
least 100 cigarettes in their life), former smokers (defined as persons who reported smoking 
at least 100 cigarettes in their life but were not currently smoking), and current smokers 
(defined as persons who reported smoking at least 100 cigarettes in their life and were 
currently smoking). Education level was categorized as having less than high school 
education (defined as completing less than 12 years of education), having a high school 
education (defined as completing 12 years of education, having a high school diploma or the 
equivalent, such as having a General Education Development or GED credential), and having 
more than a high school education (defined as completing more than 12 years of education).  
 
In both surveys body weight and height were measured following standardized 
procedures with calibrated equipment (16). Body mass index (BMI) was calculated as weight 
in kilograms divided by height in meters squared. Categories of BMI using cutpoints 
recommended by an export consultation of the World Health Organization were used: 
underweight (BMI<18.50), normal weight (BMI 18.50-22.99 and 23.00-24.99), overweight 
or pre-obese (BMI 25.00-27.49 and 27.50-29.99), and obese class I (BMI 30.00-32.49 and 
32.50-34.99), obese class II (35.00-37.49 and 37.50-39.99) and obese class III (BMI ≥40.0) 
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(17). Mid-arm circumference was measured to the nearest millimeter at the midpoint between 
the acromial and olecranon processes, on the right side unless not possible (11-13). In 
addition, in 1999-02 mid-arm circumference was measured by the physician just prior to 
blood pressure measurement in order to determine the appropriate cuff size. 
 
Survey physicians followed the then current American Heart Association 
recommendations on blood pressure measurement in both of the surveys. In 1976-80 two 
seated blood pressure measurements were taken at the mobile exam center, one at the 
beginning of the physician’s exam and one immediately following the recumbent blood 
pressure measurement. In both surveys blood pressures were taken using a mercury 
sphygmomanometer by physicians who were instructed to record blood pressures to the 
nearest two mmHg. For this analysis, hypertension was defined using the current definition 
of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC).  A person was defined as hypertensive if they had a systolic 
blood pressure of 140 mmHg or higher or a diastolic blood pressure of 90 mmHg or higher or 
reported currently being treated with anti-hypertensive medicine (18). This definition was 
applied to the mean of the two measurements in 1976-80 and to the mean of two or three 
measurements in 1999-02.   
 
In 1976-80 blood pressure cuffs of two widths were used: one 9-centimeter (cm) cuff 
and one 12-cm cuff. In 1999-02, five cuff sizes were available: a 6-cm cuff, a 9-cm cuff, a 
12-cm cuff, a 15-cm cuff, and an 18-cm cuff. The 1988 AHA recommendations for blood 
pressure measurement included corrections for blood pressures not measured with 
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appropriate cuff size that were based on a study by Maxwell and coauthors (19, 20). They 
developed equations to correct blood pressures measured with cuffs of the following sizes: 
12-cm, 15-cm, and 18-cm. We used these equations to adjust the observed blood pressures. 
In 1976-80, there were 26 participants who were measured with the 9-cm cuff for one of the 
two measurements. In 1999-02 for the one participant measured with the 6-cm cuff and 217 
participants measured with the 9-cm cuff, adjustments were made using the equation for a 
12-cm cuff since the study by Maxwell and coauthors did not include cuffs smaller than 12-
cm. Because larger cuffs were not available in the 1976-80 survey, more adjustments were 
made in overweight and obese persons who tend to have larger arm circumferences than 
normal weight persons. 
 
Blood pressures were also adjusted for zero end digit preference using an algorithm to 
impute values. In each survey dataset the mean and standard deviation of the first systolic 
blood pressure measurement was used to calculate the expected relative frequency of 
observations at 140 and 138 assuming a log normal distribution. The observed data were 
imputed so that the relative frequency of observations at 140 and 138 mmHg was equal to 
that expected in a log normal distribution. We randomly selected observations at 140 mmHg 
to impute to 138 mmHg. Diastolic pressures were adjusted in a similar fashion. 
 
Exclusions 
Of the adults 20-74 years old, 152 persons (1.3 percent) were missing one or more of 
the blood pressure measurements, 33 persons (0.3 percent) were missing BMI, four persons 
were missing information on cigarette smoking (0.03 percent), and 249 persons (2.1 percent) 
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were missing information on education level. The analytic sample consisted of 11,712 
participants for whom two complete blood pressure measurements were available. In 1999-
02 three seated blood pressure measurements were taken as part of the physician’s exam at 
the mobile exam center. Of the 8,307 adults 20-74 years old who participated in an exam, 
776 persons (8.8 percent) were missing BMI, 17 persons (0.2 percent) were missing 
information on cigarette smoking, and 22 persons (0.3 percent) were missing information on 
education level, 362 persons (4.4 percent) failed to complete the blood pressure component 
and 211 persons (2.6 percent) had less than two complete blood pressure measurements. The 
analytic sample consisted of 7,734 participants for whom two complete blood pressure 
measurements were available. 
 
Statistical Methods 
Analyses were conducted using SAS (v.9.1.3, SAS Institute, Cary, NC) and 
SUDAAN (v.9.0.1, Research Triangle Institute, Research Triangle Park, NC) with examined 
sample weights and sample design variables to account for the clustered sample design and 
produce nationally representative estimates. The sample weights incorporate differential 
probabilities of selection and adjustments for oversampling, noncoverage, and nonresponse 
(21-23). For both surveys, estimates of percent distribution of demographic characteristics 
were adjusted by the direct method to the 2000 US population age distribution using the 20-
year age intervals: 20-39 years, 40-59 years, and 60-74 years.  
 
We estimated the prevalence difference in hypertension as the difference in 
prevalence between 1999-02 and 1976-80; thus negative differences indicated a decline over 
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time.  Previous papers on trends in hypertension that reported a decline used estimates 
standardized for age with 20-year age intervals (2, 9, 24, 25). Given that our purpose was to 
consider possible explanations for this reported decline we used similar 20-year age-
standardized estimates as the base for comparisons. 
 
Log linear regression models were used to calculate predictive margins with the data 
from the two surveys combined. Predictive margins provide predicted prevalences based on 
the estimated model coefficients standardized to the distribution of the covariates included in 
the model (25-29). The predicted values for each survey are standardized to the same 
distribution of covariates and thus are standardized prevalence estimates. 
 
To evaluate the effect of measurement error, we estimated prevalences and 
differences from separate models using hypertension status adjusted for cuff size, 
hypertension status adjusted for zero end digit preference, and using hypertension status 
adjusted for both cuff size and zero end digit preference; all models included age defined 
using 20-year intervals as the independent variable. We then estimated prevalences and 
differences after standardization for measured risk factors using hypertension status as 
observed and using hypertension status adjusted for both cuff size and zero end digit 
preference. In order to examine possible variation in the prevalence difference by BMI 
category, we estimated the prevalences and differences by BMI for hypertension as observed 
and after adjustment for cuff size and zero end digit preference and with standardization for 
age (using 5-year age intervals), sex, race-ethnicity, smoking, and education. 
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Results 
There were differences between the two surveys in some demographic characteristics 
that are associated with hypertension and with obesity (Table 4.1) (30). The percent of 
persons 20-24 and 25-29 years-old decreased, the percent of persons 40-44 and 45-49 years-
old increased, the percent of non-Hispanic white persons decreased, the percent of persons 
with more than a high school education increased, and the percent of persons who reported 
never smoking increased.  
 
After standardizing to the age distribution of the combined survey population the 
difference in the observed hypertension prevalence was -8.6 points (95 percent confidence 
interval: -11.4, -5.7) and decreased with adjustment for measurement error (Table 4.2 and 
Figure 4.1). After adjustment for cuff size the age-standardized difference was about 40 
percent smaller at -5.0 points (95 percent confidence interval: -7.8, -2.3).  Adjustment for 
zero end digit preference in both surveys reduced the difference by 15 percent or -7.3 points 
(95 percent confidence interval: -10.1, -4.4). After adjustment for both sources of 
measurement error, the difference was about 44 percent smaller than the age adjusted 
estimate (-4.8 points, 95 percent confidence interval: -7.5, -2.0).  
 
The decrease in the prevalence difference after correction for cuff size was primarily 
due to decline in the prevalence estimate for 1976-80. The larger cuff size corrections seen 
for the 1976-80 estimates were because of the lack of availability of larger cuff sizes when 
participants were examined; arm circumference is correlated with BMI and thus the 
corrections for incorrect cuff size were larger for overweight and obese persons measured 
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with an incorrect cuff. For adults 20-74 years, the mean arm circumference was 31.3 cm in 
1976-80 and 33.0 cm in 1999-02 and increased with BMI level. In 1976-80 for persons 
measured with a 12-cm cuff the mean adjustment for overweight persons was -2.8 mmHg for 
systolic and -1.8 mmHg for diastolic and for obese persons the mean adjustment was almost 
twice that at -7.4 mmHg for systolic and -5.0 mmHg for diastolic. In 1999-02 for persons 
measured with a 12-cm cuff the mean adjustment for overweight persons with was -0.9 
mmHg for systolic and -0.5 mmHg for diastolic and for obese persons the mean adjustment 
was -3.3 mmHg for systolic and -2.2 mmHg for diastolic. 
 
Standardized prevalences (Table 4.3) and prevalence differences (Figure 4.2) were 
calculated before and after adjustment for measurement error from cuff adjustment and end 
digit preference.  The observed hypertension prevalence difference was about 70 percent 
larger after standardization for BMI and age (-14.7 points, 95 percent confidence interval: -
17.6, -11.7) than after standardization for age alone. This might be expected given that higher 
BMI levels are associated with a higher prevalence of hypertension and that standardization 
to the combined survey sample BMI distribution would result in estimation of hypertension 
prevalence at higher BMI levels than observed in the 1976-80 survey and lower levels in the 
later survey.  Standardization for survey differences in the proportion of each sex, race-
ethnicity and educational level made little difference in the prevalence or prevalence 
differences compared to the age standardized rates.  The possibility of residual confounding 
by age as a result of using large (20 year) categories for standardization was evaluated by 
comparing the change in prevalence difference with standardization for age using 5-year 
intervals compared with standardization for age using 20-year intervals. We found that the 
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use of finer age categories had little impact and the difference was 0.1 point smaller due to a 
0.1 reduction in the 1976-80 prevalence. After standardization for all the putative risk factors 
combined (BMI, sex, race-ethnicity, smoking, education, and age using 5-year intervals) the 
difference in hypertension prevalence between surveys was 63 percent larger than for age 
alone (-14.0 points, 95 percent confidence interval: -16.9, -10.9) and was 67 percent larger 
using measurement error corrected hypertension prevalence (-8.0 points, 95 percent 
confidence interval: -10.8, -5.1). 
 
Given our a priori interest in understanding the unexpected trends in hypertension, 
given the increase in obesity prevalence across surveys, we estimated the prevalence of 
hypertension after stratification by five BMI categories (Table 4.4, Figure 4.3) and 
standardizing for sex, race-ethnicity, age, education and smoking.  We found that the 
prevalence of hypertension increased with increasing BMI category in both surveys. Without 
corrections for measurement error the hypertension prevalence tended to increase with 
increasing BMI across the entire range. The difference in hypertension prevalence between 
surveys tended to be larger in overweight and obese subjects than in those who were 
underweight or normal weight although some confidence intervals were large and differences 
were small.  The precision of the estimates for persons with BMI<18.50 was low as seen by 
the larger standard error and wider confidence intervals, and is likely a reflection of the fact 
that this group represents only 3-4 percent of the population. 
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Discussion 
The decline in the prevalence of hypertension with the concomitant increase in 
prevalence of obesity was not fully explained by measurement error due to cuff size or end 
digit preference or by differences in BMI, sex, age, race-ethnicity, education, or smoking 
between surveys.  Similar studies in other populations have been unable to explain declines 
in hypertension (31, 32). Tunstall-Pedoe and coauthors reported a downward shift in blood 
pressure in the Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) 
study between the mid-1980’s to the mid-1990’s that was not attributable to improved 
control of hypertension (32). Danon-Hersch and coauthors investigated a secular decline in 
the association of BMI and blood pressure in adults 25-64 years old in Seychelles between 
1989 and 2004 and were unable to explain the decline by way of improved treatment (31).  
 
Changes in the US population between the two time periods that were not addressed 
in the current work may explain the decline in the prevalence of hypertension. Some of these 
changes may not have been measured in the NHANES surveys or even currently be 
identified. Dietary intake is one behavior that was measured in the surveys, but differences in 
the methodologies used made standardization across surveys difficult (33).  Intervention 
trials such as the Dietary Approaches to Stop Hypertension (DASH) and the DASH + 
Sodium trials have reported reductions in blood pressure with dietary patterns that include 
greater consumption of fruits, vegetables, and low-fat dairy foods and decreased sodium 
consumption (34, 35). Beneficial changes in diet are not likely given analysis of NHANES 
1988-2004 suggesting a decrease in the percent of hypertensive persons who follow DASH-
accordant patterns and given the trends reported for 1971-2000 for the total US population of 
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increased sodium intake and no increase in intake of fruits, vegetables, or low-fat dairy foods 
(33, 36). 
 
Recommendations to increase physical activity to reduce blood pressure in 
hypertensive and prehypertensive persons were based on studies showing  declines in blood 
pressure with moderate physical activity have led to (37). Methods differences in physical 
activity data between 1976-80 and 1999-02 prevent direct comparison of activity levels for 
the two surveys. However a decline in the proportion of adults with no leisure-time physical 
activity was reported for a more recent time period (from 1988 to 2000) (38). 
 
Limitations of this study include our inability to standardize or correct for several 
sources of measurement error that differed between the surveys. Comparability of data 
collection methods is always an important consideration in analyses comparing cross 
sectional survey data, particularly when surveys were conducted at different time periods and 
more accurate or reliable methods may have been used in later surveys. More intensive and 
frequent training for blood pressure measurement was conducted in the 1999-02 survey than 
in 1976-80. Another limitation of this study was that both surveys included measurement of 
blood pressure at only one time point and the JNC recommends that hypertension be 
diagnosed from measurements made at two or more visits. This may have biased the 
hypertension prevalence estimates upward. The proportion of persons defined as 
hypertensive based on reported use of medication has increased between 1976-80 and 1999-
02 and while it seems this would be unlikely to explain the differences shown here, the full 
impact of differences in the use of medications on hypertension prevalence is not known. 
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The small change seen in the prevalence difference after correction for measurement 
error and standardization for measured risk factors should not be interpreted as indicating 
that none of these factors had a meaningful effect on the difference. The prevalence 
difference estimated after standardization only for age was substantially different from the 
estimate after adjustment for cuff size or after standardization for BMI. This emphasizes the 
importance of not limiting analyses to age standardization or some other single adjustment, 
as in previous reports, but of evaluating and adjusting for all important confounding factors 
and sources of measurement error (2, 9, 24, 25). Prevalence estimates from the NHANES 
have an important role in scientific reviews for health policy development and evaluation and 
thus it is fitting that analyses incorporate all necessary adjustments and standardizations. 
 
The prevalence differences were attenuated after correction for cuff size, primarily 
due to declines in the prevalence estimates for 1976-80. This underscores the importance of 
the use of appropriate techniques and equipment in measuring blood pressure. The 
adjustment equations developed by Maxwell and coauthors have been applied in recent 
NHANES analyses (39, 40). Studies to confirm the validity of these adjustment equations 
would be an important contribution to research on hypertension that requires use of data 
collected without larger cuff sizes. 
 
We found that standardizing for the distribution of BMI in the combined survey 
population increased the difference in the prevalence of hypertension between the two 
surveys. This was true even after adjustment for measurement error. This indicates that obese 
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persons in the later survey had a lower rate of hypertension than obese persons in the earlier 
survey and suggests there was a change in some factor or factors that affected both normal 
weight and obese persons resulting in lower hypertension prevalence regardless of BMI. 
Furthermore, we found that while the observed prevalence difference increased across 
increasing BMI categories after adjustment for measurement error and standardization for 
age, sex, race-ethnicity, education and smoking the differences were more similar. The 
decline in hypertension in the US population between 1976-80 and 1999-02 occurred 
regardless of BMI level and was not explained by differences in risk factors examined here. 
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Table 4.1. Percent (standard error) of selected demographic characteristicsa 
 1976-80 1999-02 
Body Mass Index   
<18.50 3.3 (0.16) 2.0 (0.18) 
18.50-22.99 31.8 (0.60) 18.6 (0.55) 
23.00-24.99 19.0 (0.56) 14.4 (0.48) 
25.00-27.49 19.7 (0.53) 18.1 (0.69) 
27.50-29.99 11.7 (0.42) 16.0 (0.50) 
30.00-32.49 6.6 (0.25) 10.3 (0.35) 
32.50-34.99 3.4 (0.23) 7.6 (0.42) 
35.00-37.49 2.2 (0.13) 4.6 (0.33) 
37.50-39.99 1.0 (0.07) 3.2 (0.21) 
≥40.00 1.3 (0.13) 5.2 (0.40) 
Age in years   
20-24 14.5 (0.49) 10.6 (0.59) 
25-29 13.3 (0.42) 9.6 (0.46) 
30-34 11.2 (0.37) 11.0 (0.62) 
35-39 9.3 (0.40) 11.9 (0.60) 
40-44 8.4 (0.31) 12.2 (0.47) 
45-49 8.4 (0.31) 11.4 (0.63) 
50-54 8.8 (0.29) 10.1 (0.40) 
55-59 7.9 (0.30) 7.2 (0.41) 
60-64 7.3 (0.27) 6.0 (0.42) 
65-69 6.2 (0.21) 5.3 (0.31) 
70-74 4.6 (0.28) 4.8 (0.25) 
Sex   
Male 47.6 (0.50) 48.5 (0.49) 
Female 52.4 (0. 50) 51.5 (0.49) 
Race-ethnicity   
Non-Hispanic white 82.6 (1.40) 70.4 (1.78) 
Non-Hispanic black 10.0 (1.25) 11.2 (1.23) 
Other 7.3 (0.98) 18.4 (2.11) 
Cigarette Smoking   
Never 40.0 (0.64) 50.3 (1.23) 
Former 22.9 (0.46) 24.0 (0.87) 
Current 37.1 (0.62) 25.7 (0.90) 
Education   
Less than high school 32.7 (0.97) 23.5 (1.25) 
High school 35.6 (0.83) 25.8 (1.92) 
More than high school 31.6 (1.08) 50.7 (2.22) 
a
 All estimates other than age-specific estimates were adjusted by the direct method to the 
2000 US population using the following age groups: 20-39 years, 40-59 years, and 60-74 
years. 
  
Table 4.2. Standardized prevalence (percent) of hypertension in adults 20-74 years with correction for measurement error 
Model Standardized prevalence (standard error) 
 1999-02 1976-80 
Hypertension (observed) = Age (20-year intervals) 25.3 (0.91) 33.9 (1.12) 
Hypertension (cuff-adjusted) = Age (20-year intervals) 25.6 (0.91) 30.6 (1.09) 
Hypertension (end digit-adjusted) = Age (20-year intervals) 25.2 (0.89) 32.5 (1.13) 
Hypertension (cuff-adjusted + end digit-adjusted) = Age (20-year intervals) 25.5 (0.88) 30.3 (1.08) 
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Table 4.3. Prevalence of hypertension (HTN) standardized for selected risk factors in adults 20-74 years 
Model Percent (standard error) 
 HTN (observed) HTN (cuff-adjusted + end 
digit-adjusted) 
 1999-02 1976-80 1999-02 1976-80 
HTN  = Age (20-year intervals) 25.3 (0.91) 33.9 (1.12) 25.5 (0.88) 30.3 (1.08) 
HTN = Age (5-year intervals) 25.3 (0.92) 33.8 (1.12) 25.5 (0.89) 30.2 (1.07) 
HTN = Age (20-year intervals) + Body mass index 23.0 (0.84) 37.7 (1.24) 24.1 (0.82) 32.8 (1.19) 
HTN = Age (20-year intervals) + Sex 25.3 (0.91) 33.9 (1.12) 25.5 (0.88) 30.3 (1.09) 
HTN = Age (20-year intervals) + Race-ethnicity 25.2 (0.92) 34.0 (1.10) 25.4 (0.90) 30.4 (1.07) 
HTN = Age (20-year intervals) + Smoking 25.2 (0.92) 34.1 (1.12) 25.4 (0.89) 30.5 (1.09) 
HTN = Age (20-year intervals) + Education 25.7 (0.90) 33.0 (1.16) 25.9 (0.87) 29.4 (1.11) 
HTN = Age (5-year intervals) + Body mass index + sex + race-
ethnicity + smoking + and education 
23.2 (0.84) 37.2 (1.30) 24.3 (0.84) 32.3 (1.19) 
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Table 4.4. Standardizeda prevalence (percent) of hypertension (HTN) for 1999-02 and 1976-80 in adults 20-74 years  
by Body Mass Index (BMI) 
 HTN (observed) 
percent (standard error) 
HTN (cuff-adjusted + end digit-adjusted) 
percent (standard error) 
 1999-02 1976-80 1999-02 1976-80 
BMI     
<18.50 15.9 (3.54) 11.8 (2.38) 17.4 (3.86) 16.9 (2.66) 
18.50-24.99 13.1 (0.97) 20.7 (1.07) 15.0 (1.06) 21.5 (1.07) 
25.00-29.99 25.5 (1.49) 41.3 (1.66) 26.0 (1.26) 34.6 (1.51) 
30.00-34.99 35.6 (1.40) 55.4 (2.23) 35.2 (1.40) 42.7 (1.91) 
≥35.00 44.7 (2.37) 67.2 (2.64) 43.8 (2.06) 52.5 (2.10) 
a
 Separate models for each BMI group included adjustment for measurement error due to cuff size and zero end digit preference and 
standardization for survey, sex, race-ethnicity, age, education, and smoking. 
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Figure 4 
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Figure 4.1. Prevalence difference (95 percent confidence interval) for hypertension (HTN) in 
adults 20-74 years adjusted for measurement error
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Figure 5
Figure 4.2. Standardized prevalence difference (95 percent confidence interval) for 
hypertension (HTN)  in adults 20-74 years
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Figure 6 
Figure 4.3. Standardized prevalence difference (95 percent confidence interval) for 
hypertension in adults 20-74 years by BMI group
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NOTE: Differences were standardized for age, sex, race-ethnicity, education, and smoking. 
  
5. Conclusion 
This project used existing nationally representative data to further our understanding 
of trends in hypertension and obesity.  We demonstrated that two sources of measurement 
error affected the prevalence of hypertension in 1976-80. The adjustment for cuff size 
changed the estimated prevalence of hypertension in 1976-80 from 34 to 31 percent, while 
only a slight difference was seen in the estimate for 1999-02 after correction for cuff size. 
The high proportion of blood pressure measurements with zero end digits in 1976-80 
indicates that this was a common bias in the survey. We modeled the effect of zero end digit 
preference using two different assumptions, one extreme assumption and one more 
reasonable assumption. For 1976-80, both modeled estimates were different from the 
observed prevalence, and the difference between the observed prevalence and the modeled 
prevalence was larger when using the more extreme assumption. The difference between the 
observed prevalence and the adjusted prevalence was larger after adjustment for cuff size 
than after adjustment for zero end digit preference. The lack of larger size cuffs was an 
important source of error in the 1976-80 survey. The modeled estimates were only slightly 
different from those using the observed data for 1999-02, indicating that the effects of these 
two sources of measurement error were slight in the more recent survey. 
 
Measurement error also affected the prevalence difference, increasing it by about 40 
percent. Furthermore while the prevalence difference appeared to increase with increasing 
BMI group after standardization only for age, after correction for cuff size and zero end digit
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preference the prevalence differences were similar in obese, overweight, and normal weight 
persons. This suggests that whatever factors explain the decline in hypertension seen in 
normal weight persons also affected obese and overweight persons. Differences in the BMI 
distribution between 1976-80 and 1999-02 confounded the prevalence difference; this can be 
seen by the 70 percent increase in the prevalence difference after standardization to the BMI 
distribution of the combined survey population. This resulted primarily from an increase in 
the 1976-80 prevalence after standardization for BMI and age; there were fewer obese 
persons in 1976-80 than in 1999-02, but hypertension was more prevalent in obese persons in 
1976-80 than in 1999-02. 
 
In addition to the difference in the BMI distributions in the two populations, the 
demographics of the US population changed between 1976-80 and 1999-02. In 1999-02 the 
population was somewhat older, with fewer non-Hispanic whites, more people had a high 
school education or more, and there were fewer current smokers and more people who had 
never smoked. This study demonstrates that differences in the distribution of these 
characteristics do not explain the difference in prevalence of hypertension. The decline in 
hypertension between 1976-80 and 1999-02 remains unexplained. Differences in unmeasured 
or unknown risk factors may explain the difference. Cross-sectional studies in other 
populations also have been unable to explain declines in hypertension (1, 2). A study by 
Ulmer and coauthors in Austria suggested a birth cohort effect as a possible explanation for 
the decline in hypertension between 1985-05 observed in that study (3). This hypothesis 
would be interesting to investigate in the US population but cannot be tested using the 
NHANES since it requires longitudinal data. 
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A limitation in trends analyses using NHANES is possible differences in methods 
used for data collection. This possibility increases when comparisons are made for data 
spanning several decades as in the current study. It is incumbent upon researchers to 
investigate methods differences and the error such differences may induce. I evaluated the 
error present in the data due to zero end digit preference. Because this appeared to be an 
important source of error I conducted a sensitivity analysis to model the effect of this error. 
Even if a ready-made adjustment is not available an effort should be made to evaluate the 
effect of each source of error and to develop an adjustment if possible. 
 
In this study the prevalence differences standardized for selected risk factors were 
compared to the prevalence difference standardized for only age because this is what many 
papers on trends in hypertension prevalence using NHANES have used for comparisons (4-
7). I demonstrated that after standardization for just one additional factor there were changes 
in the prevalence difference as well as after adjustment for measurement error. The purpose 
of these comparisons was to demonstrate the inadequacy of standardization for just one 
potential confounder. Reports presenting the latest prevalence estimates from NHANES are 
sometimes in the form of a brief report much appreciated by busy readers. However the 
desire for simplicity should not lead to incomplete evaluation and adjustment of 
measurement error and confounders. One strength of the NHANES is the breadth and depth 
of measurements and information collected from each survey participant. Even brief reports 
presenting prevalence of a health indicator should take advantage of the other data collected 
which may be used to evaluate possible confounding of the prevalence estimates. Initiatives 
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such as the Healthy People 2010 use the NHANES for tracking many health indicators (8). 
Comparisons that omit evaluation of possible confounders do a disservice to policymakers 
and others who use such tracking reports. The primary and oft-quoted purpose of the 
NHANES is to provide data for monitoring and tracking the health and nutritional status of 
the US population (9-11). I demonstrated that if such tracking is done with estimates that are 
minimally adjusted for error and confounding, this ignores the wealth of data collected in 
NHANES. It is important that the NHANES not only continue to collect data used to monitor 
health indicators such as hypertension, but also that data be collected on characteristics and 
behaviors that might be important confounders of trends in hypertension.  
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Appendix A. Supplemental Results 
 
 
  
Table A.1. Prevalence of hypertension for persons 20-74 years age-adjusting using different age group intervals 
Age group 
interval 
Prevalence (%) Standard 
error 
Coefficient of 
variation (%)a 
95% 
confidence 
limits 
Confidence 
interval widthb 
1976-80 
Crude 33.3 1.07 3.21 31.2, 35.5 1.14 
20 yearsc 34.2 1.11 3.26 31.9, 36.5 1.14 
10 yearsd 34.2 1.14 3.33 31.9, 36.6 1.15 
5 yearse 34.2 1.14 3.33 32.0, 36.6 1.14 
1999-02 
Crude 25.2 0.94 3.73 23.4, 27.2 1.16 
20 yearsc 25.1 0.87 3.47 23.4, 26.9 1.15 
10 yearsd 25.1 0.86 3.45 23.4, 26.9 1.15 
5 yearse 25.1 0.87 3.46 23.4, 26.9 1.15 
a
 Coefficient of variation calculated as C.V. = (S.E./percent) 
b Confidence interval width calculated as CI width = (upper limit/lower limit) 
c 20 years: 20-39 years, 40-59 years, 60-74 years 
d 10 years: 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-74 years 
e 5 years: 20-24 years, 25-29 years, 30-34 years, 35-39 years, 40-44 years, 45-49 years 50-54 years, 55-59 years, 60-64 
years, 65-69 years, 70-74 years 
 
86 
  
Table A.2. Observed prevalence (%) of hypertension from NHANES 
 1976-80 1999-02 
  Age adjusted  Age-adjusted 
Ages (years) Crude 1980 population 2000 population Crude 1980 population 2000 population 
18-74 31.9 31.3 32.9 24.3 22.9 24.1 
18 and older    28.1 26.4 28.3 
20-74 33.3 32.8 34.2 25.2 24.1 25.1 
20 and older    29.1 27.7 29.4 
Note: Estimates were adjusted by the direct method to the specified US population standard using the following age 
groups: 20-39 or 18-39 years, 40-59 years, and 60-74 years or 60 years and older 
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Table A.3. Adjusteda prevalence ratios (95% confidence intervals) for hypertension by BMI and survey 
Hypertension BMI 18.5-24.9 BMI 25.0-29.9 BMI≥30.0 
1976-80    
Observed 1.00 1.67 (1.55, 1.80) 2.40 (2.21, 2.61) 
End digit-adjustedb 1.00 1.69 (1.58, 1.82) 2.42 (2.23, 2.62) 
Cuff-adjustedc 1.00 1.34 (1.24, 1.45) 1.72 (1.58, 1.87) 
Cuff- and end digit-adjustedbc 1.00 1.36 (1.25, 1.47) 1.75 (1.61, 1.89) 
1999-02    
Observed 1.00 1.55 (1.33, 1.81) 2.27 (1.98, 2.61) 
End digit-adjustedb 1.00 1.54 (1.33, 1.80) 2.27 (1.98, 2.62) 
Cuff-adjustedc 1.00 1.37 (1.19, 1.58) 1.94 (1.70, 2.21) 
Cuff- and end digit-adjustedbc 1.00 1.38 (1.19, 1.59) 1.94 (1.71, 2.22) 
a
 Models included BMI, age, sex, race, education, smoking. 
b Adjusted for zero end digit preference. 
c
 Adjusted for inappropriate cuff size. 
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Table A.4. Prevalencea of hypertension by BMI, survey, age, race-ethnicity, education, and smoking 
 BMI 18.5-24.9  BMI 25.0-29.9  BMI≥30.0 
 1976-80  1999-02  1976-80  1999-02  1976-80  1999-02 
 % SE  % SE  % SE  % SE  % SE  % SE 
20-39 years 9.2 0.99  3.8 0.78  18.1 1.48  6.3 1.20  28.0 2.66  14.7 1.80 
40-59 years 30.2 1.82  18.6 1.72  40.3 2.14  27.6 1.98  52.6 2.22  44.2 1.55 
60-74 years 52.0 1.92  53.6 2.96  61.0 1.62  62.6 2.41  72.0 1.79  69.3 2.42 
                  
Non-Hispanic 
black 
34.6 2.44  32.2 1.72  42.6 2.96  36.5 1.65  50.5 2.89  43.5 1.96 
Non-Hispanic 
white 
23.5 1.13  15.9 1.21  33.3 1.75  22.5 1.53  44.5 1.66  34.3 1.39 
                  
Men 27.0 1.37  16.6 1.44  34.9 1.98  24.1 1.38  47.9 2.43  36.0 1.88 
Women 22.6 1.12  18.5 1.31  31.8 1.62  23.8 1.48  42.8 1.54  35.1 1.22 
                  
Less than high 
school 
26.8 1.47  22.4 2.12  36.8 1.95  26.5 1.38  46.9 2.38  36.9 2.02 
High school 24.5 1.46  18.8 1.75  34.2 1.90  23.8 1.87  42.9 2.30  40.0 2.69 
More than high 
school 
21.7 1.38  16.2 1.14  30.4 2.01  22.8 1.74  43.6 3.24  32.7 1.53 
                  
Never smoked 25.6 1.52  15.7 1.38  35.9 1.79  24.6 1.54  47.3 1.54  36.6 1.67 
Former smoker 23.6 1.39  22.1 1.91  34.9 2.30  24.3 2.00  43.0 2.56  37.1 1.94 
Current smoker 24.1 1.35   17.4 1.36   31.4 1.68   22.5 2.09   43.8 2.77   32.0 2.02 
a Estimates are adjusted for use of inappropriate cuff size and for end digit preference. 
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Table A.5. Adjusteda prevalence ratios for hypertensionb by survey, BMI category, age, and race-ethnicity 
 1976-80 1999-02 
 BMI 18.5-24.9 BMI 25.0-29.9 BMI≥30.0 BMI 18.5-24.9 BMI 25.0-29.9 BMI≥30.0 
Age (years)       
20-39 1.00 1.72 (1.41, 2.11) 3.00 (2.37, 3.79) 1.00 1.53 (0.89, 2.65) 3.84 (2.45, 6.00) 
40-59 1.00 1.31 (1.15, 1.48) 1.61 (1.39, 1.87) 1.00 1.47 (1.17, 1.84) 2.27 (1.88, 2.74) 
60-74 1.00 1.15 (1.07, 1.24) 1.33 (1.23, 1.43) 1.00 1.17 (1.01, 1.36) 1.26 (1.10, 1.43) 
       
Race-ethnicity       
Non-Hispanic Black 1.00 1.34 (1.09, 1.64) 1.50 (1.28, 1.76) 1.00 1.15 (0.98, 1.36) 1.39 (1.17, 1.65) 
Non-Hispanic White 1.00 1.38 (1.28, 1.50) 1.81 (1.66, 1.97) 1.00 1.46 (1.20, 1.78) 2.10 (1.75, 2.51) 
       
Men 1.00 1.34 (1.19, 1.50) 1.78 (1.62, 1.96) 1.00 1.57 (1.22, 2.01) 2.14 (1.69, 2.70) 
Women 1.00 1.38 (1.24, 1.55) 1.70 (1.52, 1.90) 1.00 1.29 (1.06, 1.56) 1.83 (1.53, 2.19) 
       
Less than high school 1.00 1.26 (1.16, 1.38) 1.53 (1.40, 1.68) 1.00 1.21 (1.00, 146) 1.52 (1.27, 1.82) 
High school 1.00 1.37 (1.20, 1.56) 1.74 (1.49, 2.03) 1.00 1.32 (1.00, 1.75) 2.08 (1.67, 2.59) 
More than high school 1.00 1.42 (1.20, 1.67) 2.12 (1.75, 2.56) 1.00 1.47 (1.19, 1.81) 2.07 (1.72, 2.50) 
       
Never smoker 1.00 1.36 (1.18, 1.56) 1.71 (1.52, 1.92) 1.00 1.61 (1.30, 2.00) 2.35 (1.94, 2.84) 
Former smoker 1.00 1.40 (1.23, 1.59) 1.64 (1.43, 1.89) 1.00 1.10 (0.90, 1.36) 1.46 (1.20, 1.79) 
Current smoker 1.00 1.29 (1.13, 1.48) 1.91 (1.67, 2.19) 1.00 1.36 (1.03, 1.79) 1.99 (1.57, 2.54) 
a
 Adjusted for sex, race-ethnicity, education, and smoking. 
b Hypertension status was adjusted for use of inappropriate cuff size and for end digit preference. 
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Table A.6. Adjusteda prevalence odds ratios (95% confidence intervals) for hypertension by BMI and survey 
Hypertension BMI 18.5-24.9 BMI 25.0-29.9 BMI≥30.0 
1976-80    
Observed 1.00 2.25 (2.01, 2.53) 5.38 (4.61, 6.27) 
End digit-adjustedb 1.00 2.28 (2.03, 2.56) 5.24 (4.54, 6.04) 
Cuff-adjustedc 1.00 1.59 (1.40, 1.79) 2.63 (2.29, 3.02) 
Cuff- and end digit-adjustedbc 1.00 1.61 (1.42, 1.83) 2.69 (2.34, 3.09) 
1999-02    
Observed 1.00 1.89 (1.29, 2.77) 4.16 (2.87, 6.02) 
End digit-adjustedb 1.00 1.86 (1.28, 2.70) 4.16 (2.87, 6.02) 
Cuff-adjustedc 1.00 1.63 (1.19, 2.25) 3.47 (2.50, 4.83) 
Cuff- and end digit-adjustedbc 1.00 1.64 (1.19, 2.26) 3.49 (2.50, 4.87) 
a
 Models included BMI, age, sex, race, education, smoking. 
b Adjusted for zero end digit preference. 
c
 Adjusted for inappropriate cuff size.
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Table A.7. Prevalence of hypertension by survey, age, race-ethnicity, education, smoking, and BMI 
 1976-80 1999-02 
 Observed Adjusteda Observed Adjusteda 
20-39 years     
BMI 18.5-24.9 9.3 (0.86) 9.2 (0.99) 2.5 (0.52) 3.8 (0.78) 
BMI 25.0-29.9 25.2 (1.56) 18.1 (1.48) 6.0 (1.24) 6.3 (1.20) 
BMI≥30.0 43.5 (3.09) 28.0 (2.66) 15.4 (1.95) 14.7 (1.80) 
40-59 years     
BMI 18.5-24.9 28.7 (1.68) 30.2 (1.82) 15.6 (1.50) 18.6 (1.72) 
BMI 25.0-29.9 47.5 (2.30) 40.3 (2.14) 27.4 (2.21) 27.6 (1.98) 
BMI≥30.0 66.8 (1.97) 52.6 (2.22) 44.7 (1.73) 44.2 (1.55) 
60-74 years     
BMI 18.5-24.9 49.8 (1.80) 52.0 (1.92) 50.9 (2.80) 53.6 (2.96) 
BMI 25.0-29.9 64.8 (1.56) 61.0 (1.62) 60.9 (2.64) 62.6 (2.41) 
BMI≥30.0 80.8 (1.42) 72.0 (1.79) 69.5 (2.31) 69.3 (2.42) 
     
Non-Hispanic black     
BMI 18.5-24.9 35.1 (2.51) 34.8 (2.50) 29.1 (1.43) 32.2 (1.72) 
BMI 25.0-29.9 50.2 (2.98) 42.0 (2.92) 35.5 (1.84) 36.5 (1.65) 
BMI≥30.0 62.9 (2.97) 50.4 (2.90) 45.2 (2.10) 43.5 (1.96) 
All other race-ethnicities     
BMI 18.5-24.9 22.9 (1.05) 23.8 (1.09) 14.4 (1.03) 16.4 (1.16) 
BMI 25.0-29.9 39.5 (1.73) 33.1 (1.62) 22.2 (1.46) 22.6 (1.24) 
BMI≥30.0 58.2 (1.74) 44.1 (1.52) 34.6 (1.51) 34.3 (1.35) 
     
Less than high school     
BMI 18.5-24.9 25.9 (1.32) 26.8 (1.47) 22.6 (2.69) 23.7 (2.54) 
BMI 25.0-29.9 42.6 (2.15) 36.8 (1.95) 22.0 (2.00) 21.2 (1.83) 
BMI≥30.0 60.1 (2.37) 46.9 (2.38) 39.8 (2.60) 37.6 (2.18) 
High school     
BMI 18.5-24.9 23.6 (1.33) 24.5 (1.46) 13.2 (2.83) 14.7 (2.45) 
BMI 25.0-29.9 39.8 (2.10) 34.2 (1.90) 24.4 (3.88) 24.4 (2.94) 
BMI≥30.0 58.7 (2.60) 42.9 (2.30) 43.2 (3.98) 41.4 (3.47) 
More than high school     
BMI 18.5-24.9 20.8 (1.62) 21.7 (1.38) 13.8 (1.12) 14.5 (1.34) 
BMI 25.0-29.9 39.4 (2.27) 30.4 (2.01) 23.8 (3.29) 22.5 (2.95) 
BMI≥30.0 55.2 (3.73) 43.6 (3.24) 34.8 (2.97) 33.8 (2.72) 
     
Never smoked     
BMI 18.5-24.9 23.9 (1.52) 25.6 (1.52) 13.7 (1.01) 15.7 (1.38) 
BMI 25.0-29.9 42.1 (1.85) 35.9 (1.79) 23.9 (1.64) 24.6 (1.54) 
BMI≥30.0 61.6 (1.98) 47.3 (1.54) 37.6 (1.87) 36.6 (1.67) 
Former smoker     
BMI 18.5-24.9 23.0 (1.51) 23.6 (1.39) 19.1 (1.67) 22.1 (1.91) 
BMI 25.0-29.9 43.2 (2.32) 34.9 (2.30) 24.1 (2.23) 24.3 (2.00) 
BMI≥30.0 57.8 (3.30) 43.0 (2.56) 37.9 (2.12) 37.1 (1.94) 
Current smoker     
BMI 18.5-24.9 23.6 (1.28) 24.1 (1.35) 15.6 (1.37) 17.4 (1.36) 
BMI 25.0-29.9 37.4 (2.12) 31.4 (1.68) 22.0 (2.19) 22.5 (2.09) 
BMI≥30.0 56.8 (2.59) 43.8 (2.77) 31.2 (2.07) 32.0 (2.02) 
a Estimates are adjusted for use of inappropriate cuff size and for end digit preference.
  
Table A.8. Adjusteda prevalence odds ratios for hypertensionb by survey, BMI category, age, and race-ethnicity 
 1976-80 1999-02 
 BMI 18.5-24.9 BMI 25.0-29.9 BMI≥30.0 BMI 18.5-24.9 BMI 25.0-29.9 BMI≥30.0 
Age (years)       
20-39 1.00 1.89 (1.50, 2.38) 3.95 (2.91, 5.35) 1.00 1.04 (0.39, 2.77) 5.63 (2.90, 10.94) 
40-59 1.00 1.51 (1.24, 1.84) 2.26 (1.76, 2.90) 1.00 1.98 (1.33, 2.95) 4.16 (2.83, 6.10) 
60-74 1.00 1.40 (1.19, 1.64) 2.18 (1.79, 2.64) 1.00 1.40 (0.85, 2.32) 1.73 (1.00, 3.01) 
Race-ethnicity       
Non-Hispanic 
Black 
1.00 1.61 (1.12, 2.31) 2.15 (1.58, 2.93) 1.00 1.48 (0.90, 2.42) 2.02 (1.21, 3.35) 
All other race-
ethnicities 
1.00 1.60 (1.40, 1.83) 2.76 (2.36, 3.22) 1.00 1.64 (1.15, 2.34) 3.79 (2.51, 5.73) 
a
 Adjusted for sex, race-ethnicity, education, and smoking. 
b Hypertension status was adjusted for use of inappropriate cuff size and for end digit preference. 
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Table A.9. Prevalence of hypertension by survey, BMI category, and age 
 1976-80 1999-02 
 Observed Adjusteda Observed Adjusteda Predictedb 
BMI<25.0      
20-39 years 9.1 (0.84) 9.1 (0.98) 3.4 (0.53) 4.1 (0.73) 9.0 (0.08) 
40-59 years 28.3 (1.65) 30.2 (1.79) 18.6 (1.75) 19.6 (1.80) 28.4 (0.25) 
60-74 years 49.1 (1.72) 51.6 (1.74) 53.9 (2.76) 54.5 (2.70) 48.7 (0.26) 
BMI 25.0-29.9      
20-39 years 25.3 (1.56) 18.1 (1.47) 6.0 (1.24) 6.3 (1.20) 17.6 (0.18) 
40-59 years 47.5 (2.30) 40.5 (2.14) 27.4 (2.21) 27.7 (2.03) 38.0 (0.32) 
60-74 years 64.7 (1.56) 60.8 (1.71) 60.9 (2.64) 63.0 (2.33) 58.1 (0.31) 
BMI=>30.0      
20-39 years 43.6 (3.15) 28.4 (2.71) 15.4 (1.95) 14.8 (1.80) 27.0 (0.14) 
40-59 years 67.5 (1.93) 52.1 (2.33) 44.7 (1.73) 44.2 (1.56) 49.0 (0.20) 
60-74 years 81.1 (1.50) 72.1 (1.79) 69.5 (2.31) 69.1 (2.50) 69.9 (0.22) 
a Estimates are adjusted for use of inappropriate cuff size and for end digit preference. 
bPredicted using PROC SCORE approach with model coefficients from 1976-80 model including: BMI, sex, age, race-
ethnicity, education, smoking, BMI*age interaction, and BMI*race-ethnicity interaction.
94 
  
  
Figure 7
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Figure A.1. Prevalence ratio (95% CI) of hypertension for obese adults 
(body mass index, BMI =30)
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Figure 8 
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Figure A.2. Prevalence ratio (95% CI) of hypertension for obese adults 
(body mass index, BMI =30) by age group
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